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ABSTRACT 
NANCY BARCHUS BLOCK. The Role of the Insulin Receptor Tyrosine Kinase 
in Two Models of Insulin Resistance. (Under the direction of MARIA 
G. BUSE.) 
Activation of the insulin receptor tyrosine kinase in vitro and in 
vivo was studied in two rat models of insulin resistance: hyper-
cortiso1emia and streptozotocin-induced diabetes. In control rats, 
intravenous insulin administration resulted in dose-dependent in vivo 
activation of the skeletal muscle insulin receptor kinase. Chronic 
cortisone treatment did not affect the kinase activity of receptors 
solubilized from muscle after activation with insulin in vivo or in 
vitro. In contrast, diabetes depressed skeletal muscle insulin 
receptor kinase activation in vivo by -50%. Diabetes impaired the in 
vitro insulin stimulation of receptor kinase activity from skeletal 
muscle and liver towards the substrate histone H2b, but not towards the 
synthetic substrate poly glu-tyr (4:1). To understand the mechanisms 
underlying the substrate selective effects of diabetes, kinetics of 
insulin receptor tyrosine kinase activity solubilized from control and 
diabetic liver were examined. Both substrates, histone H2b and poly 
glu-tyr (4:1), inhibited insulin-stimulated autophosphorylation and 
exogenous kinase activity when substrates were added prior to 
activation of receptors with ATP. Inhibition of insulin-stimulated 
exogenous kinase activity by H2b was more marked with diabetic-derived 
insulin receptors, resulting in a -70% lower maximal kinase activity 
towards this substrate compared to receptors isolated from control 
rats. When receptors were allowed to autophosphorylate prior to 
addition of H2b, substrate inhibition of kinase activity was minimal or 
absent and the difference in maximal kinase activity between control· 
and diabetic- derived receptors was reduced to -25%. Kinetics of 
insulin receptor kinase activity towards poly glu-tyr (4:1) were 
unaltered by diabetes. Effects of substrate-inhibition and diabetes on 
insulin receptor kinase activity showed tissue-specific differences. 
Liver-derived H2b kinase activity was inhibited to a greater extent by 
H2b than that from muscle, and the effects of diabetes were greater in 
liver than muscle. The intrinsic (uninhibited) muscle insulin receptor 
tyrosine kinase was unimpaired by diabetes. Conclusions: The insulin 
resistance associated with hypercortiso1emia occurs distal to the 
receptor kinase. In vivo activation of the skeletal muscle insulin 
receptor tyrosine kinase is impaired by diabetes. Diabetes associated 
impairment of the insulin receptor kinase activated in vitro reflects 
mainly enhanced susceptibility of the receptor to inhibition by some 
substrates, e.g., H2b. This defect, which may result in impaired 
signalling appears selective for substrates. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
I. INTRODUCTION 
Insulin is an anabolic peptide hormone with multiple effects on 
its target cells. These effects include: 1) activation of the 
transport of molecules such as glucose, amino acids and ions across 
the plasma membrane (284); 2) acute activation or inhibition of 
intracellular enzymes involved in intermediary metabolism (62,256); 
3) regulation of gene expression (84); 4) translocation of membrane 
proteins such as the glucose transporter (52,249,258). and the type II 
insulin·1ike growth factor receptor (62,162); and 5) stimulation of 
cell growth (257). Activation of enzymes and transport occurs over 
relatively short time periods (seconds to minutes) while processes 
leading to cell growth and proliferation occur over much longer periods 
of time (hours). Pleotypic effects of insulin are observed in many 
cell types, however some effects are tissue-specific. Much of our 
understanding of insulin's actions is based upon its effects in the 
three major physiologic target tissues in mammals: muscle, liver and 
adipose tissue. 
Despite intense efforts to elucidate the mechanisms involved in 
insulin action, the exact sequence of events which lead to effects 
following insulin binding remain undefined. Insulin's actions are 
initiated upon binding to a specific receptor on the surface of its 
target cells. A vast amount of knowledge concerning the structure and 
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function of the insulin receptor has been obtained (reviewed in 
53,86,129,225 J 187) but evidence concerning the regulation of insulin 
receptor function and it's coupling to insulin's effects is still 
incomplete. Studies presented in this dissertation addressed the 
regulation of insulin receptor structure and function in two animal 
models of insulin resistance in two major target tissues. 
II • INSULIN RECEPTOR STRUCTURE 
A. Biochemical Studies: 
The insulin receptor is found in virtually all mammalian cell 
types. Because the number of insulin receptors (-102 - 105 per cell) 
is relatively low compared to most p~oteins (62,114,129), much of the 
initial information regarding the structure of the receptor was derived 
from tissues such as human placenta and rat liver from which large 
amounts of the protein could be purified, or from cultured cell lines 
labelled with receptor precursors. Biochemical studies in several 
laboratories (81,103,105,116,117,118,135,170,171,207) revealed that the 
insulin receptor is a heterotetramer transmembrane glycoprotein 
consisting of 2 a subunits (M.W. ~135 kDa) and 2 a subunits (M.W. -95 
kDa) linked by disulfide bonds in a S-S-S-a-a-S-S-6 configuration 
(depicted in figure 1). The a subunits contain the ligand binding 
domain and reside totally extracellularly while the a subunits are 
transmembrane peptides, containing a small extracellular domain, a 
membrane spanning domain and a much larger intracellular domain. 
Pulse chase studies with IM-9 lymphocytes (104) and 3T3-Ll cells 
(223) showed that the receptor is synthesized as a single polypeptide 
(180-190 kDa) which is cotrans1ationally glycosy1ated. Following 
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core-N-1inked glycosylation to a high mannose form in the endoplasmic 
reticulum (210 kDa), the precursor is transferred to the Golgi where 
the single chain is cleaved to form -125 kDa and -85 kDa subunits. 
These subunits are then further processed in the Golgi by conversion to 
a low mannose form, and addition of other monosaccharides including 
glucosamine, fucose and sialic acid. Both the mature a and 8 subunits 
are glycosylated, with a greater amount of galactose and 
N-acetylglucosamine in the former and a higher sialic acid content in 
the latter (105). Inhibitors of glycosylation result in the intracel-
lular accumulation of aglycoreceptor protein and decreased cell surface 
binding (224,226). Removal of these inhibitors results in the 
appearance of fully glycosylated forms of the previously accumulated 
protein, indicating that glycosylation may be necessary for insertion 
of the receptor into the plasma membrane (226). The insulin receptor 
is also post-translationally modified by palmitic and myristic 
acylation. This modification has been shown to be necessary for the 
interaction of proteins with the plasma membrane (271). 
B. Molecular Biology: 
The basic structure was confirmed after cloning and sequence 
analysis of the human placental insulin receptor independently by 
Ullrich et a1. (273) and Ebina et al. (69). cDNA sequence analysis by 
these two groups was essentially identical except that one group 
reported a sequence of 1370 amino acids while the other group's 
sequence was longer by 12 amino acids at the 3' end of the a subunit. 
These differences were attributed to isolation of different mRNA 
species used for cDNA synthesis. Sequence analysis identified a leader 
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peptide sequence at the amino terminus of the a subunit which is 
cleaved after insertion of the proreceptor into the endoplasmic 
reticulum membrane, and a domain of cationic amino acids which forms 
the cleavage site yielding the a and B subunits. The region encoding 
the B subunit revealed a sequence of hydrophobic amino acids encoding 
the membrane spanning domain, in addition to a consensus sequence for 
ATP binding and a region encoding phosphotransferase activity. 
Sequencing also revealed multiple potential glycosylation sites and 
regions of high cysteine content in the a subunit t whereas the B 
subunit contained lower quantities of both types of residues. The 
predicted M.W. from sequence analysis is 82 kD for the a subunit and 69 
kD for the 8 subunit; the differences between predicted and observed 
M.W. likely owing to glycosylation and anomalous migration on 
SDS-PAGE. 
The insulin receptor contains significant sequence homology to the 
tyrosine kinase family of oncogenes and other growth factor receptor 
tyrosine kinases, including the epidermal growth factor (EGF) , platelet 
derived growth factor (PDGF), and the insulin·like growth factor 1 
(IGF-l) receptors (69,273,296). Highly homologous regions in these 
receptors include the ligand binding (including cysteine-rich regions), 
ATP binding and phosphotransferase domains. Exceptional structural and 
functional similarity exists between between the insulin receptor and 
the insulin-like growth factor I receptor (115,118,255,274,296) and 
between their respective ligands (222). Both receptors share binding 
of each other's ligands, albeit at very different ligand concentrations 
(27,209 t 222). 
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Southern blot analysis after treatment of DNA with restriction 
enzymes indicated that there is only one insulin receptor gene in 
humans (273) while northern blot analysis indicated multiple mRNA 
species in humans (2 main species) and at least 2 in rats (69,273), 
suggesting that insulin receptor mRNA is processed differently. Using 
the polymerase chain reaction, Seino et ale (245) showed that alternate 
mRNA splicing leads to two mRNA isoforms in several human tissues 
(liver, kidney, brain, spleen and adipose) and in IM-9 lymphocytes and 
Hep G2 cells. In addition the abundance of the two types of 
transcripts varies between different tissues and cell lines. 
Differences in the migration of insulin receptors from different 
tissue types on SDS-PAGE have been observed in rats (28,107) and humans 
(35) and were attributed in part to altered sialylation of insulin 
receptor S subunits (28). Alternative mRNA splicing is a common 
mechanism for the generation of protein isotypes; whether differences 
in the structures detected between tissues after SDS-PAGE are due to 
alternative splicing is unknown. 
III. INSULIN BINDING 
A. Kinetics: 
Equilibrium insulin binding to solubilized receptors, isolated 
plasma membranes and intact cells reveals complex interactions. 
Scatchard plots of insulin binding are generally curvilinear indicative 
of either at least two distinct affinity binding sites or 
negative cooperativity between two or more similar sites (53). 
Evidence for negative cooperativity was first shown by DeMeyts et ala 
(60,61) where excess unlabelled insulin promoted dissociation of the 
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labelled bound hormone from cultured lymphocytes and most recently in 
highly purified receptor preparations (280). Using a similar 
experimental design, however, Pollet et al. (210) found enhanced 
dissociation of bound hormone from cultured lymphocytes under 
conditions in which binding site occupancy decreases and argued against 
negative cooperativity as an explanation for nonlinear binding 
kinetics. In addition, evidence for positive cooperativity has been 
demonstrated at very low insulin concentrations (64,65). The proposed 
symmetrical a282 structure lead early investigators to believe that two 
kinetically distinct binding sites exist per receptor molecule with the 
potential for binding site cooperativity between the two sites. 
However, studies in several laboratories indicated that only 1 mol of 
insulin binds per mol of receptor (21,201.259). 
B. Structural Components of the Receptor Involved in Insulin 
Binding: 
Additional studies provided insight into the structural basis for 
complex insulin binding kinetics. Mild reduction of solubilized 
insulin receptors with dithiothreiotol (DTT) selectively reduces 
sulfhydryl bonds between a subunits, generating two a-S-S-S 
heterodimers (20,21,185,259,260). After separation of experimentally 
generated placental insulin receptor tetramers and dimers by gel 
filtration, Koch et a1. (147) observed that optimal insulin binding to 
the two types of receptor species occurs at different pH and ionic 
strengths. Scatchard Plots indicated a single low affinity binding 
site in the dimer form, and a distinct high and low affinity binding 
site in the tetramer (259). At saturation, one molecule of insulin was 
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bound per dimer or tetramer. The authors suggested that half site 
binding reactivity in dimers indicates that insulin binding to tetra-
mers displays either absolute negative cooperativity or that the 
subunits are associated assymetrically. Curvilinear Scatchard plots of 
insulin binding to the isolated tetramer fractions suggested that 
multiple native forms (possibly higher association states of individual 
subunits) of the receptor exist. Alternatively, the association of 2 
dimer halves may form a complete high affinity binding site in the 
tetramer and the low binding affinity component observed in tetramer 
fractions may be due to contamination by a small number of dimers. 
The 02 82 form of the insulin re~eptor is the predominant species 
detected in vivo (53). a-S-S-8 Dimers have been isolated from liver 
plasma membranes without the addition of DTT (147,169). Whether these 
dimers were artifacts of the preparation or exist natively in vivo is 
unknown. Data presented in chapter three of this dissertation suggest 
the former. 
Sulfhydryl interactions may play a role in insulin action and 
insulin receptor activation (discussed in section VII). An early study 
by Maturao et al suggested that disulfide exchange occurs in the 
insulin receptor upon insulin binding because changes in the 
hydrodynamic state of the receptor were observed following insulin 
binding and were mimicked by DTT (172). Yip and colleagues (297) 
localized the insulin binding site to the cysteine-rich region of the 
subunit after proteoltyic digestion of the a subunit labelled with a 
photoreactive insulin analog. In this study, transfection of insulin 
receptors mutated by deletion of this site into chinese hamster ovary 
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(CHO) cells failed to increase insulin binding to these cells whereas 
transfection of the same amount of normal receptors increased binding 
"10 fold. 
Glycosylation of cell surface proteins has long been recognized as 
an important component of interactions with extracellular molecules. 
The role that glycosylation of the insulin receptor plays in insulin 
binding or action is not well defined. Removal of terminal sialic acid 
residues from the insulin receptor with neuraminidase was shown to have 
either no effect (134) or resulted in increased insulin binding (82). 
Removal of adipocyte cell surface sialic acid residues by levels of 
neuraminidase which had no effect on insulin receptor sialic acid 
residues markedly reduced the ability of insulin to stimulate 
lipogenesis and inhibited receptor recycling indicating a role of 
non-receptor glycoconjugates in insulin action (101). 
IV • INTERNALIZATION OF INSULIN AND ITS RECEPTOR 
A. Characterization: 
Several morphologic and biochemical studies have shown that the 
insulin-receptor complex is internalized following insulin binding 
(8,11,74,136,154,168,218,240). This process, termed ttreceptor-mediated 
endocytosis" is the means by which many types of ligands, including 
LDL, transferrin, asialoglycoproteins, mannose glycoconjugates, 
lysosomal enzymes and a2-macrog1obulin, enter cells and reach their 
intracellular destination (74,111). Morphologic studies indicated that 
insulin initially binds diffusely on the cell surface, but then 
aggregates into patches before it is internalized (240). Internali-
zation of the insulin receptor can be mimicked by binding of some 
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antibodies directed against the a subunit of the insulin receptor which 
inhibit insulin binding (127). Aggregation of the receptor 
(127,192,239), stimulation of glucose transport in rat adipocytes (127) 
and activation of solubilized liver insulin receptor kinase activity 
(106) (discussed in section V) was induced by the binding of bivalent 
Fab fragments, but not monovalent fragments of these antibodies indi-
cating that receptor aggregation is an important event in insulin 
action. 
Internalized insulin receptors have been shown to have at least 
three fates (111): Insulin receptor complexes can be 1) rapidly 
recycled back to the cell surface (74,89), 2) sequestered in an 
intracellular compartment (154), or 3) degraded by lysosomes (11,168). 
Half life of the receptor is believed to be largely a result of the 
rate of degradation (287). In the absence of insulin it is -9-12 
hours. Upon short term exposure to insulin most receptors are cycled 
back to the plasma membrane (74). However, after long term exposure 
to insulin, receptor degradation increases (136,146) resulting in a 
decrease in the number of plasma membrane receptors. This phenomenon, 
termed ndown-regulation" is characteristic of many types of receptors 
after chronic exposure to ligand (49,126) and may be responsible for 
altered response to insulin in some cells under conditions associated 
with hyperinsulinemia (76) (discussed in section X). Conversely, 
receptor number is increased or "up-regulated tt under conditions where 
circulating insulin levels are low (30,123). 
B. Consequences of Internalization: 
Some of insulin's effects may depend on internalization of the 
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hormone. Inhibition of internalization or intracellular processing 
with monensin, chloroquine or methylamine selectively blocked some of 
insulin's effects in several cell types (66,86,213). While specific 
binding of insulin to intracellular organelles; including the Go1gi 
apparatus, endoplasmic reticulum and nucleus have been demonstrated 
(87), the consequences of these interactions are uncertain. Maller et 
al. (166) and Miller et ale (180) demonstrated increases in ribosomal 
S6 phosphorylation, RNA synthesis and protein synthesis following 
microinjection of insulin into Xenopus oocytes. In addition Miller 
(179) showed that RNA and protein synthesis could be stimulated by 
applying insulin to isolated nuclei and isolated cytoplasm, 
respectively, from Xenopus oocytes. These last three studies indicate 
that at least some of insulin's effects can be e1icted after bypassing 
the plasma membrane. Whether insulin exerts these effects in vivo by 
this mechanism is questionable, since effects seen in the cell free 
systems were additive to insulin applied externally to cells. 
V • THE INSULIN RECEPTOR TYROSINE KINASE 
A. Identification and Characterization: 
Phosphorylation of the S subunit of the insulin receptor in 
response to insulin was demonstrated initital1y in cultured human 
lymphocytes by Kasuga et a1. (137). This event was subsequently 
verified in a number of cell types and in cell free systems. In 
intact cells the phosphorylation occurred on both serine and tyrosine 
residues (95,137,202,292), while in cell free systems, phosphorylation 
was primarly on tyrosines (7,138 t 303). Additionally, insulin 
stimulated the tyrosine phosphorylation of proteins added to detergent 
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extracts of cells or purified receptor preparations (205,304). While 
it was originally postulated that phosphorylation resulted from a 
distinct protein kinase which copurified with the insulin receptor, 
further studies using insulin receptors purified to near homogeneity 
indicated that the tyrosine kinase activity was an intrinsic property 
of the insulin receptor (109,303,306). Serine phosphorylation 
presumably occurs by the action of distinct intracellular and/or 
membrane bound kinases which are activated in response to insulin 
(54,202). 
The kinase activity of the insulin receptor has been characterized 
by numerous independent groups. The phosphotransferase activity was 
localized to the S subunit after selective trypsin digestion of the 
subunit was shown to abolish kinase activity without affecting insulin 
binding (229) and by demonstration of an ATP binding site in this 
subunit (228,246). Rosen et al. (227) originally showed that tyrosine 
kinase activity towards exogenously added substrates in cell free 
systems was enhanced when the insulin receptor was allowed to 
phosphorylate prior to addition of substrates, indicating that 
autophosphorylation of the insulin receptor activated its intrinsic 
kinase activity. It was subseqently shown by several groups that 
autophosphorylation occurs on several sites of the S subunit (at least 
11), but that activation of exogenous kinase activity correlated only 
with the phosphorylation of some tyrosine residues within a specific 
tryptic domain (109,269,303). White et a1. (286) further showed that 
phosphorylation of different tryptic domains occurred with different 
time courses. Utilizing antiphosphotyrosine antibodies to trap the 
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receptor in a given phosphorylation state followed by conditions which 
inhibited further autophosphorylation, this group showed that 
autophosphorylation of the 8 subunit proceeds via a cascade in 
receptors isolated from Fao hepatoma cells (290). Progression of the 
cascade to two sites (tyr 1146 and either 1150 or 1151) in the critical 
domain (designated the tyr 1150 domain) resulted in partial activation 
and subsequent phosphorylation of a third site in this domain resulted 
in full activation of exogenous kinase activity in vitro. The cascade 
was completed by phosphorylation of two other sites (tyr 1316 and 1322) 
near the COOH terminus, which had no effect on activation. 
The extent of insulin receptor ~utophosphorylation and exogenous 
kinase activity parallels receptor occupancy by insulin (7); with 
solubilized receptors, half maximal binding and half maximal kinase 
activity occur with -2 X 10- 9 M insulin. After the insulin receptor is 
activated by autophosphorylation, the presence of insulin is no longer 
required for continued activity (227,306). Insulin stimulates insulin 
receptor tyrosine kinase activity by increasing the Vmax for ATP, while 
the Km for ATP is unaltered (156,187). The kinase activity is 
dependent on either Mn2+ or Mg2+ which decrease the Km for ATP 
(156,187), thus the concentrations of these cations required for 
maximal activity are highly dependent on ATP concentrations. Under in 
vitro conditions, where typically < 0.5 mM ATP is utilized, the 
reaction utilizes Mn2+ in preference to Mg2+. 
Autophosphorylation may not be absolutely necessary for activation 
of exogenous insulin receptor tyrosine kinase activity: Following 
incubation of highly purified placental insulin receptors with 
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concentrations of substrates which completely inhibited 
autophosphorylation, a two fold insulin stimulation of exogenous kinase 
activity was still observed (186). In addition, some types of insulin 
receptor antibodies can stimulate exogenous kinase activity without 
increasing insulin receptor autophosphorylation (12). 
B. Regulation: 
Dephosphorylation of the receptor by experimental addition of 
alkaline phosphatase results in inactivation of previously activated 
receptors in vitro (97,303). Using pulse-chase techniques in 
permeabilized rat adipocytes, Mooney et ale (182) showed that 
phosphorylated receptors are rapidly dephosphorylated (by 2 minutes). 
Klein et a1. (144) and Backer et a1. (8) showed that internalized 
phosphorylated adipocyte and Fao hepatoma cell receptors are 
dephosphorylated more rapidly than those on the plasma membrane. 
Inactivation in vivo presumably occurs by the action of intracellular 
phosphatases since phosphatase activity is not detected in highly 
purified receptor preparations (97). 
Comparison of autophosphorylation in vivo with that in vitro by 
several groups indicates that some tyrosines which are phosphorylated 
in vitro seem not to be accessible to phosphorylation in vivo 
(18,32,290,292). In Fao hepatoma cells, phosphorylation of the third 
critical site did not occur in vivo (292), however insulin binding to 
intact rat adipocytes (143) and intact rat skeletal muscle (32) 
resulted in essentially full receptor activation indicating that 
regulation in vivo may vary with cell type. Examination of phos-
phorylation over time in vivo by Pang et a1. (202) showed that the 
14 
insulin receptor is phosphorylated initially on tyrosines in response 
to insulin and subsequently on serine and threonine residues. 
Phosphorylation on serine and threonine residues decreases the 
exogenous tyrosine kinase activity of the receptor and is elicited in 
vivo by administration of agents which increase cAMP or by phorbo1 
esters (115,263,264). Receptor preparations are also phosphorylated on 
serine residues in vitro by protein kinase C resulting in decreased 
tyrosine kinse activity (19). Serine and threonine phosphorylation, 
thereby serve as a mechanism to regulate insulin receptor tyrosine 
kinase activity. 
Effects of proteolysis on autophosphory1ation and exogenous kinase 
activity are controversial. Mild trypsinolysis of the 8 subunit of 
receptors from Fao cells decreased autophosphorylation due to the loss 
of tyr 1316 and 1322 residues; however this treatment did not affect 
the activation of exogenous phosphotransferase activity towards a 
synthetic peptide substrate corresponding to amino acid residues 1143 
to 1152 (thr-12-lys) of the human insulin receptor (290). Receptors 
similarly degraded by a membrane splitting proteinase possessed 
decreased autophosphorylation and normal maximal exogenous kinase 
activity towards a synthetic peptide substrate (poly glu-tyr 4:1)t but 
apparently decreased affinity for the substrate (244). However, others 
found that proteolytic degradation resulting in barely detectable 
molecular weight changes, resulted in abolition of placental insulin 
receptor autophosphorylation and exogenous kinase activity towards 
histone H2b and thr~12·lys (140). In contrast, mild proteolysis of the 
asubunit apparently activates insulin receptor tyrosine kinase activity 
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(161) (discussed in secion VII). 
VI. THE INSULIN RECEPTOR TYROSINE KINASE AND SIGNAL TRANSDUCTION 
Several lines of evidence indicate that activation of the insulin 
receptor tyrosine kinase is a necessary event for most of insulin's 
biologic actions. 
A. Studies with Antibodies: 
Antibodies against the 8 subunit which inhibit insulin receptor 
autophosphorylation and exogenous tyrosine kinase activity inhibited 
multiple insulin sensitive pathways (including short and long term 
effects of insulin) when introduced intracel1ular1y by microinjection 
into Xenopus oocytes (183) or by osmotic lysis of pinocytotic vessicles 
that contained the antibodies in rat adipocytes, HepG2 and CHO cells 
(184). Antibodies against the S subunit which do not inhibit insulin 
receptor tyrosine kinase activity had no effect. 
An antibody against the ~ subunit which activated the insulin 
receptor kinase, stimulated amino acid transport but not cell proli-
feration in hepatoma cells (211). These results support an alternative 
proposed mechanism of r~ceptor activation whereby insulin binding may 
serve only to alter the conformation of the receptor, resulting in 
non-covalent interaction of the receptor with plasma membrane proteins 
similar to receptor systems which interact with G-proteins (129). This 
interaction may be essential for coupling to some, but not all of 
insulin's effects. While this is a p1ausable mechanism, results 
obtained with antibodies must be interpreted cautiously because 
insulin-mimetic actions of antibodies may proceed by mechanisms other 
than which actually occur in response to insulin in vivo.(212). 
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B. Mutation of the Insulin Receptor: 
Selective mutation of the cloned insulin receptor gene proved to 
be a powerful tool for elucidating the mechanisms involved in insulin 
receptor activation and for establishing the role of the kinase in 
coupling to post-receptor events. Site-directed mutagenesis at either 
the ATP binding site (40,68) or at a critical tyrosine (tyr 1150) (71) 
resulted in kinase deficient receptors without altering insulin 
binding, internalization or processing. CHO cells expressing the 
kinase deficient receptors after transfection with the mutated insulin 
receptor gene were considerably less sensitive to insulin than cells 
transfected with the normal insulin receptor gene; with regards to 
glycogen synthesis, thymidine incorporation into DNA, hexose uptake, 
ribosomal protein 56 kinase activation t endogenous tyrosine 
phosphorylation of cellular proteins and serine and threonine 
phosphorylation of the insulin receptor. 
Expression of a similarly mutated (ATP binding site) human kinase 
deficient receptor in rat 1 fibroblasts was shown to inhibit: a) 
stimulation of hexose uptake, b) receptor internalization and c) 
endogenous insulin receptor function in vivo at the level of substrate 
phosphorylation even though autophosphorylation of the endogenous 
receptor was not impaired (164). This study indicated that exogenous 
kinase activity in addition to autophosphorylation is necessary for 
generating insulin's signal, at least with regards to glucose uptake. 
Interestingly, the kinase deficient receptors did not inhibit 
phosphorylation of substrates in vitro when mixed with normal 
receptors; however, the different results could be due to potentially 
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limiting substrate levels in vivo vs the use of saturating substrate 
levels in vitro. 
Not surprisingly, two studies indicated that other features of the 
insulin receptor molecule are important for signal transduction: 1) 
Mutation of the insulin receptor at tyrosine residue 960 did not affect 
autophosphory1ation or exogenous substrate (thr-12-1ys) phosphorylation 
by the receptor in vitro (288). These results are consistent with 
results of biochemical studies indicating that phosphorylation of this 
site is not necessary for activation of exogenous kinase activity 
(290). 2) Experimental truncation of the insulin receptor by mutation 
of the carboxyl terminus of the gene.also did not affect 
autophosphorylation or exogenous kinase activity towards a synthetic 
polypeptide (poly glu·tyr 4:1) in vitro (163,175). Neither of these 
two mutated receptors were biologically active when expressed in CHO 
cells or rat 1 fibroblasts and the first mutation resulted in markedly 
decreased phosphorylation of an endogenous substrate (pp185). Both of 
these studies confirmed that autophosphory1ation is not sufficient for 
transmission of insulin's signal and further supported a role of 
exogenous protein kinase activity in signal transmission. In addition, 
results from these studies indicate that altered insulin receptor 
structure induced by some mutations may alter recognition of endogenous 
substrates but not synthetic peptide substrates. Therefore, these 
studies suggest that the synthetic peptide substrates utilized for in 
vitro assays may not be good models for the in vivo substrates. 
Results presented in chapter three of this dissertation indicate that 
structural alterations in the insulin receptor induced by diabetes may 
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be expressed towards synthetic peptides differently than globular 
proteins. 
VII.. CONFORMATION OF THE INSULIN RECEPTOR AND SIGNAL TRANSDUCTION 
Insulin induced conformational changes and association between 
subunits are crucial events in signal transduction by the receptor. 
Early evidence for a conformational change following insulin binding 
was shown by altered response of the receptor to radiation inactiva-
tion (98) increased susceptibility of the a subunit to proteases 
(161,208), altered receptor mobility in molecular sieving columns 
(172), a shift to higher insulin binding affinity (64,65), potentiation 
of reducing agents (293) and by changes in kinase activity. 
A number of agents (trypsin, H202, DTT) which are insulinmimetic, 
alter the structure of the insulin receptor and activate the insulin 
receptor tyrosine kinase (113,121,151,248,261,285). Several lines of 
experimentation which include the use of these agents indicate that the 
a subunit exerts inhibitory control of 8 subunit kinase activ~ty and 
that insulin binding to the a subunit releases the S subunit from this 
inhibitory control: Trypsin digestion of the a subunit using either' 
solubilized receptors or intact cells confered constitutive kinase 
activity upon the a subunit (113,248). Truncation of the a subunit by 
deletion mutagenesis and expression in CHO cells resulted in a 
constitutively elevated insulin-independent uptake of glucose (70). In 
liver membranes, insulin binding resulted in proteolytic degradation of 
the a subunit by an endogenous protease without degradation of the B 
subunit (161), even though in vitro it is the 8 subunit which is 
selectively sensitive to exogenously added proteases (140,229) 
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suggesting that a proteolytic event may be involved in activation of 
the kinase by insulin in vivo. Mild reduction with DTT results in the 
formation of two a-B dimers and increased insulin independent B subunit 
kinase activity (260). Activation by this agent therefore also 
involves a release of constraints by the a subunit structure. 
Interaction between a-B dimers appears to be necessary for full 
activation of the insulin receptor tyrosine kinase as insulin stimula-
ted autophosphory1ation of a-S dimers is lower than native tetramers 
(20,260). However, the lower insulin-stimulated kinase activity may be 
due to elevated basal levels. Autophosphorylation promotes 
reassociation of dimers to tetramers as demonstrated by sizing 
chromatography of isolated dimers before and after exposure to ATP and 
Mn2+ (185). Examination of the reassociated species by non-reducing 
SDS-PAGE indicated that in the presence of insulin the reassociation is 
covalent; in the absence of insulin it is not (185). 
One of the obvious questions which arose soon after the discovery 
of the phosphotransferase activity of the B subunit, was whether 
autophosphorylation occurs through an intra- or inter- molecular 
reaction. Dilution was shown not to affect autophosphorylation of 
solubilized receptors indicating an intramolecular reaction (246). 
However. the existence of two 8 subunits per tetramer raised the 
possibility of several mechanisms: the phosphorylation of each subunit 
by itself, cross·phosphorylation of one 8 subunit by the other, or a 
combination of both mechanisms. Results from two experiments suggested 
the second mechanism: 1) Dimers immobilized on WGA failed to 
autophosphorylate (20) and 2) dilution of receptor dimers decreased the 
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rate of autophosphorylation in a dilution-dependent manner (260). 
VIII. ENDOGENOUS SUBSTRATES FOR THE INSULIN RECEPTOR KINASE 
Several insulin sensitive enzymes are regulated by phosphory-
lation/dephosphorylation mechanisms. These include glycogen synthase, 
pyruvate dehydrogenase, cAMP phosphodiesterase, acetyl-CoA carboxylase 
and ribosomal S6 kinase (62,225). Most of these enzymes are activated 
by dephosphorylation in response to insulin and until recently (214) 
only serine and threonine phosphorylation was detected in the enzymes 
which are activated by phosphorylation. This lead to the hypothesis 
that other serine and threonine kinases or phosphatases were 
phosphorylated by the insulin receptor on tyrosine, which in turn 
phosphorylated or dephosphorylated insulin sensitive enzymes. Early 
attempts to identify in vivo substrates for the receptor demonstrated 
tyrosine phosphorylation of several proteins in different cells types, 
although the identity or role that most of these proteins play in 
mediating insulin's signal is unknown (1,14,16,97,112,206,232,167, 
124,289). Four of these phosphoproteins deserve mention as specific 
properties which may re,late to signal transduction by insulin have been 
identified: 
1) Colca et a1. (45) reported insulin stimulated tyrosine 
phosphorylation of calmodulin in intact adipocytes. Calmodulin, a 
ubiquitous calcium binding protein, regulates a number of calcium-sen-
sitive enzymes (39). Insulin has been shown to increase Ca2+ and 
calmodulin binding to adipocyte plasma membranes and to inhibit 
calmodulin-dependent plasma membrane Ca2+ and Mg2+ ATPase (45). The 
insulin receptor specifically binds calcium and calmodulin (45); 
21 
however, phosphorylation of calmodulin in vitro by the insulin receptor 
has an absolute requirement for cationic peptide cofactors including 
polylysine t histone H2b and the carboxyl terminus of C-Ha-ras 
(90,23l t 295). 
2) O'Brien et a1. (190) reported phosphorylation of a 60 kDa GDP 
binding protein on tyrosyl residues following insulin stimulation of 
mouse NIH-3T3 cells and suggested that this protein was an 
insulin-sensitive G protein. Krupinski et a1. (153) had previously 
demonstrated that insulin receptors can phosphorylate the Go or Gi 
proteins of the adenylate cyclase system in detergent solubilized 
systems and after incorporation of the receptor and the G proteins into 
phospholipid vesicles. In addition purified placental insulin 
receptors phosphorylated purified N-ras p21 protein (a member of the G 
protein family (37» in an insulin dependent manner in vitro (150). 
Furthermore, microinjection of antibodies directed against H-ras p2l 
into Xenopus oocytes inhibited insulin, but not progesterone stimulated 
maturation of these cells (150). In a variety of cell types, insulin 
stimulates the hydrolysis of an inositol-glycan mediator which 
subsequently activates insulin senstive enzymes (73,235). This effect 
occurs following activation of an inositol-specific phospholipase C. 
It has been suggested that this function may be mediated by 
interaction of the insulin receptor with a G protein, similar to other 
receptor systems which activate phospholipase C (43). 
3) Microtubule associated protein-2 (MAP-2) kinase is a 
serine/threonine specific kinase which activates ribosomal S6 kinase 
from Xenopus oocytes (216). Tyrosine phosphorylation of MAP-2 kinase 
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was detected after exposure of 3T3-Ll cells to insulin (217). 
Increased S6 phosphorylation has been associated with increased protein 
synthesis in Xenopus oocytes, swiss mouse 3T3 fibroblasts and rat 
adipocytes (262). In pancreatic acini, 56 kinase was activated in a 
time and dose-dependent manner by insulin (262). 
4) Most recently, Pyne et a1. (214) demonstrated that insulin 
stimulates tyrosine phosphorylation and activation of the 52 kDa 
peripheral plasma-membrane cyclic AMP phosphodiesterase in intact 
hepatocytes (214). In addition, prior treatment of hepatocytes with 
glucagon, a catabolic hormone which acts antagonistically to insulin, 
prevents the phosphorylation and activation. This finding is 
especially significant, as this is the first protein whose function is 
known to be regulated by insulin and the consequences of its function 
on a cellular process known. 
IX. IN VITRO MEASUREMENT OF INSULIN RECEPTOR KINASE ACTIVITY 
Studies involving assessment of insulin receptor kinase activity 
in vitro rely on the use of exogenously added substrates. While 
purification procedures resulting in highly purified receptors are 
essential for determination of activity intrinsic to the receptor, 
procedures resulting in the highest degree of purity involve elution of 
receptors from insulin or antibody affinity columns under relatively 
harsh conditions. Glycosyl residues in the receptor enables affinity 
purification by immobilized lectins (103) involving elution at neutral 
pH with competetive sugars J and results in insulin receptors with 
greatly increased kinase activities compared to those eluted under 
harsh conditions (186,221). Therefore, assessment of kinase activity 
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in vitro is often p~rformed on WGA purified receptors; a semi-purified 
preparation which contains other glycoproteins including other 
membrane-bound tyrosine kinases. 
Several synthetically derived or other exogenously added 
substrates are used to assess insulin receptor tyrosine kinase activity 
in vitro. The most commonly used substrates include histone H2b, a 
synthetic copolymer of glutamic acid and tyrosine residues (poly glu-
tyr 4:1), a synthetic peptide corresponding to the phosphorylation 
sequence of the src oncogene product (src related peptide), angiotensin 
II, and a synthetic peptide corresponding to the insulin receptor 
subunit sequence between residues 1143 and 1152 (thr-12-lys). Most of 
these polypeptides serve as excellent substrates for several tyrosine 
kinases, but often with different kinetics (23,142,238,247,254,276). 
In addition, only the IGF-l receptor possesses binding cross-reactivity 
with insulin but requires -100 fold higher levels of insulin than the 
insulin receptor to achieve similar levels of receptor occupa~cy 
(27,28,302). Therefore in vitro reactions stimulated by insulin are 
relatively specific for the insulin receptor even though basal 
activities may be contributed by copurified tyrosine kinases. Recently 
a purification scheme has been described in which receptors can be 
eluted from insulin affinity columns under relatively mild conditions 
and results in highly purified receptors possessing kinase activity 
similar to that of WGA preparations (221). The use of this method may 
allow more sensitive means to asses insulin receptor kinase activity in 
vitro in the future. 
Many substrates for the insulin receptor tyrosine kinase inhibit 
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insulin stimulated insulin receptor autophosphorylation and exogenous 
kinase activity at levels above their Km, when substrates are added 
before addition of, or simultaneously with ATP during insulin receptor 
activation (23,148,156,233,248). In general, if insulin receptors are 
maximally activated by autophosphorylation before the addition of 
substrates, no inhibition of autophosphorylation or insulin receptor 
tyrosine kinse activity is observed. Some synthetic polymers were 
shown to inhibit exogenous kinase activity when added either prior to 
or after autophosphorylation; however higher levels of substrate were 
needed to inhibit kinase activity when added after vs before 
autophosphorylation (233). 
The mechanism of inhibition by substrates is not well understood 
because; a) knowledge concerning receptor activation is still incom-
plete and b) few have attempted to define the mechanism. Domains 
involved in substrate binding and the number of substrate binding sites 
per receptor are not known. Shoelson et al. (248) showed that 
inhibition of exogenous kinase activity by substrate analogues does not 
involve competition with binding of ATP. Data presented in chapter 
three of this dissertation indicate that substrate inhibition by H2b 
also does not involve competition with ATP. Shoelson et a1. suggested 
that tyrosine residues 1146, 1150 and 1151 of the insulin receptor are 
in spatial proximity to the substrate binding portions of the kinase 
catalytic active sites. They hypothesized that binding of substrate 
before ATP binding and phosphorylation prevents the transfer of 
phosphate from ATP to the critical sites on the receptor, thereby 
preventing activation. Under these conditions the rate of exogenous 
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substrate phosphorylation would be similar to the unactivated receptor. 
If ATP binds before substrate, the transfer of phosphate to the 
critical residues is unabated, resulting in activation of the kinase 
before substrate binds. Activation of the epidermal growth factor 
receptor and pp60v-src kinases may also be inhibited by this same 
mechanism (248). Whether substrate inhibition is important in 
regulation of insulin receptor tyrosine kinase activity in vivo is 
unclear at this time. 
x. INSULIN RESISTANCE 
Insulin resistance is a state in which a given level of the 
hormone produces a subnormal effect. Classically, insulin resistance 
is defined either by the dose of insulin resulting in a half maximal 
response or the maximal response achievable by the hormone. An effect 
on the dose eliciting half maximal effect is defined as a change in 
sensitivity, while an altered maximal effect is defined as a change in 
responsiveness (125,126~. Insulin resistance can occur at many levels 
of insulin action including binding of the hormone to its receptor, 
signal transduction by ~he receptor or at a plethora of post-receptor 
events. Receptor defects include altered insulin binding (either 
affinity or total number) and altered insulin receptor tyrosine kinase 
activity. These two types of insulin receptor defects can result in 
decreased insulin sensitivity (a shift to the right in the 
dose-response curve) or decreased responsiveness. A decrease in the 
binding affinity would be expected to result in decreased sensitivity 
with unaltered responsiveness, while a decrease in the number of 
binding sites would be expected to alter sensitivity and 
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responsiveness. However, in some cell types, including skeletal muscle 
(159) and adipose tissue (149) only a small fraction of the total 
number of receptors need to be occupied with hormone to elicit a 
maximal effect (114). The unoccupied receptors are termed "spare 
receptors". A significant decrease in the total number of receptors 
may not alter the responsiveness in these cells if the number of 
receptors is still sufficient to elicit a maximal response. 
A variety of clinical conditions and disease states are either a 
result of or accompanied by insulin resistance. These include obesity, 
noninsulin-dependent diabetes mellitus (NIDDM), insulin dependent 
diabetes mellitus (lDDM), sepsis, trauma and burns (Reviewed in 
3,50,75,76,126,155,197,267,279). In obese humans (6,36), obese rats 
(158,198) and patients with NIDDM (6,34,78,189,251); decreased numbers 
of receptors (34,35,78,158,251) (likely due to down regulation by 
chronically elevated insulin levels) and/or defective insulin receptor 
tyrosine kinase activity is observed (6,34,35,78_189,251). The 
mechanisms responsible for decreased kinase activity in NIDDM has been 
addressed by two groups. In one study Brillon et al. (24) compared the 
precipitability with antiphosphotyrosine antibodies of 
insulin-stimulated phosphorylated insulin receptors from liver of 
patients without or with NIDDM. Only -50% of the receptors from 
patients with NIDDM were precipitated compared to -100% in controls. 
Therefore two populations of receptors seem to exist in NIDDM, half of 
them are kinase competent while the other half are not. Obermaier-
Kusser et a1. (189) showed t~at defective in vitro autophosphorylation 
and exogenous kinase activity of insulin receptors from skeletal muscle 
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of patients with NIDDM was due to defective autophosphorylation at the 
third critical site. 
Most of the work described in this dissertation involves insulin 
receptor function in insu1inopenic diabetes in rats (a model of IDDM). 
Defects in insulin receptor kinase activity have been observed in 
receptors isolated from muscle (32) and liver (123,195) of animals with 
experimentally induced insulinopenic diabetes. However, Amatruda et 
ale (4) and Truglia et a1. (272) reported no effect of streptozotocin 
(SIZ) induced-diabetes on insulin receptor autophosphorylation and 
tyrosine kinase activity in liver or adipose tissue. Furthermore Bak 
et a1. (9) reported unaltered tyrosine kinase activity of insulin 
receptors isolated from insulin resistant skeletal muscle of patients 
with 100M. Reported discrepancies in the effects of insulinopenia on 
insulin receptor tyrosine kinase activity have been attributed to 
different experimental protocols (discussed in chapters two, three and 
four of this dissertation). Much of the data was obtained from insulin 
receptors solubilized from tissues with non-ionic detergents and 
partially purified on WGA agarose. Data presented in chapter two of 
this dissertation indicates that activation of exogenous kinase 
activity in vivo is decreased in skeletal muscle of insulinopenic rats 
after insulin binding in vivo. In a study by Burant et a1. (32) 
separation of receptor subunits by SDS-PAGE revealed a subpopulation of 
insulin receptor e subunits derived from muscles of STZ-diabetic rats 
with decreased electrophoretic mobility. After partial digestion with 
V-B protease, differences between control and diabetic-derived subunits 
became more evident. Treatment with glycosidases suggested that excess 
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sialylation may account in part for the altered mobility of diabetic 
derived a subunits. The altered mobility and altered kinase activity 
were reversed by chronic insulin therapy. Whether the ,structural 
alteration is responsible for observed altered kinase activity is 
unknown. Data presented in chapter three address the mechanisms 
responsible for the observed decreased activation of the liver insulin 
receptor upon insulin binding in vitro. These data suggest that 
diabetes induced structural alterations render increased susceptibility 
of the receptor tyrosine kinase to inhibition by the substrate H2b. 
Data presented in chapter five suggest that the same mechanism occurs 
in muscle in vitro. 
Many hormones which act antagonistically to insulin produce an 
insulin resistant state when present in supraphysiologic levels. These 
include catecholamines (86 t l97 t 267) glucagon (197,267) and glucocorti-
colds (3,75,267). A number of disease states are accompanied by 
increased levels of these insulin-antagonists; including type 1 
diabetes (50,67) sepsis and various states of trauma (279). 
Catecholamine treatment of isolated human adipocytes was shown to 
decrease both insulin binding affinity and insulin receptor auto-
phosphorylation (86). Glucocorticoids mayor may not affect insulin 
binding, however even when present, altered binding does not account 
for the observed insulin resistance (discussed in chapter two of this 
dissertation). A study by Truglia et ale (272) and data presented in 
chapter two of this dissertation (18) suggest that glucocorticoid 
induced insulin resistance occurs at steps distal to the receptor. 
Decreased insulin receptor tyrosine kinase activity has been 
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observed in patients with familial forms of moderate to severe insulin 
resistance including lipoatrophic diabetes (165) and type A insulin 
resistance (91,92). Defects in kinase activity in these syndromes has 
been attributed to various mutations in the insulin receptor gene 
(122,193,266,300). The mechanisms responsible for defective tyrosine 
kinase in these syndromes are probably different than those in NIDDM 
and IDDM; as defects accompanying the latter two are aquired rather 
than genetic, ie. they are corrected by normalization of altered 
metabolism which accompanies these disease states (30,80,123). 
XI. S~Y 
In summary, considerable advances in the understanding of insulin 
receptor function have been accomplished in the past 15 years. One of 
the most important being the discovery of the insulin receptor tyrosine 
kinase. That the insulin receptor tyrosine kinase is important for 
most, if not all of insulin's actions is fairly certain. However, 
definition of endogenous substrates for the kinase must be accomplished 
before a complete understanding of the role of the insulin receptor 
tyrosine kinase in insulin action can be achieved. In addition the 
role of the insulin receptor tyrosine kinase in various states of 
insulin resistance is still unclear. Studies in this dissertation 
addressed the role of the insulin receptor tyrosine kinase in two 
insulin resistant states. These studies involved: 1) the role of the 
insulin receptor in the insulin resistance of skeletal muscle 
associated with hypercortisolemia (chapter two); 2) activation of the 
skeletal muscle insulin receptor tyrosine kinase in vivo, and effects 
of insulinopenic diabetes on the in vivo activation of the insulin 
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receptor tyrosine kinase (chapter two); 3) structural differences 
between the rat muscle and liver insulin receptor (chapter four); and 
4) the mechanisms underlying defective in vitro insulin receptor 
tyrosine kinase activity in liver (chapter three) and skeletal muscle 
(chapter five) in insulinopenic diabetes. 
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CHAPTER II 
EFFECTS OF HYPERCORTISOLEMIA AND DIABETES 
ON SKELETAL MUSCLE INSULIN RECEPTOR FUNCTION 
IN VITRO AND IN VIVO 
The contents of this chapter have been previously published in similar 
form in Am. J. Physiol. 256:E39-E48, 1989. 
INTRODUCTION 
Insulin resistance is characteristic of many disease states 
including non-insulin dependent (NIDDM, type 2) diabetes (76), 
uncontrolled insulin-dependent (IDDM,type 1) diabetes (30,58), 
hypercortisolemia (3), obesity (76) and uremia (3). Although various 
defects in insulin action have been reported in these conditions, the 
mechanisms involved have not been adequately defined. Insulin's 
actions are initiated upon insulin binding to its receptor, a 
heterotetramer glycoprotein composed of two a and two a subunits 
linked by disulfide bonds (87,225). Insulin binding to the a subunit 
induces a conformational change in the receptor resulting in 
autophosphorylation on tyrosine residues of the S subunit. Autophos-
phorylation on critical site(s) activates the insulin receptor 
exogenous tyrosine kinase. This activation is the first known event 
upon insulin binding and is believed to mediate various biological 
effects of insulin (reviewed in 87,225). 
While insulin's effects are anabolic, those of the glucocorticoids 
are largely catabolic (3,215). Glucocorticoid excess is associated 
with increased glucose production in liver (3); decreased peripheral 
glucose transport and utilization (3,63,196,265,272); decreased protein 
synthesis and increased protein degradation in muscle (215). The 
mechanism by which glucocorticoids antagonize the effects of insulin is 
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poorly understood. Alterations in insulin binding to its receptor have 
been reported following administration of various glucocorticoids 
(3,33,63,110,128,145,196,199), however the results vary with type of 
glucocorticoid (63), length of administration (33,199), type of tissue 
studied (199) and whether the glucocorticoid is administered in vivo or 
in vitro (13,34). No consistent correlation between alterations in 
binding and altered insulin response has been observed in various 
hypercortisolemic states, leading to the conclusion that a post-binding 
mechanism is responsible for the insulin resistance (33,63,199,265). 
A post-receptor defect has been demonstrated in adipocytes and 
fibroblasts following dexamethasone administration involving increased 
translocation of glucose transporters from the plasma membrane to 
intracellular sites (reviewed in 110). A recent study reported 
unaltered in situ insulin receptor autophosphorylation and exogenous 
kinase activity of solubilized insulin receptors from insulin resistant 
adipocytes of dexamethasone treated rats (272). Previous studies have 
not investigated whether altered insulin receptor tyrosine kinase 
activation occurs in muscle during hypercortisolemia. 
Impaired insulin receptor kinase activation may play a role in the 
insulin resistance of insulinopenic diabetes. Insulin receptors 
solubilized from liver (123,195) and muscle (30) of severely 
insulinopenic diabetic rats show decreased basal and insulin stimulated 
autophosphorylation and exogenous tyrosine kinase activation. 
Furthermore, treatment of streptozotocin diabetic rats with insulin for 
3 days improves insulin sensitivity in muscle (277), and restores 
autophosphorylation and exogenous kinase activity of the muscle insulin 
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receptor to control levels (30). While decreased insulin receptor 
kinase activity has been reported in various insulin resistant states 
including insulinopenia (30,123,195), NIDDM (34,78), fasting (79) and 
obesity (35,158), these reports are of solubilized receptors exposed to 
insulin in vitro. Insulin receptor kinase activation in vivo has not 
been investigated in any of these conditions. 
Recently, methods have been described to assess the in vivo 
activation state of the insulin receptor in intact cells (143) and 
animals (29). In the present study, we examined the activation of 
muscle insulin receptors by insulin administered in vivo to control 
rats and to two rat models of insulin resistance: insulinopenic 
diabetes and hypercortisolemia. We report that insulin stimulates the 
muscle insulin receptor in vivo in a dose-dependent manner. 
Streptozotocin diabetes results in decreased insulin stimulated 
activation of the muscle insulin receptor kinase in vivo, and therefore 
supports the data from in vitro studies. Finally, insulin binding and 
tyrosine kinase activation is unaltered in receptors isolated from 
skeletal muscle of hyp~rcortisolemic rats after exposure to insulin in 
vitro or in vivo, suggesting that glucocorticoids antagonize the 
effects of insulin at steps distal to the receptor. 
MATERIALS AND METHODS 
Materials: Streptozotocin was a gift from Upjohn Research Labora-
tories (Kalamazoo, MI). Monocomponent, crystalline pork insulin was a 
gift from Dr. Ronald Chance and monoiodinated Al4[125 I ]-insulin from 
Dr. B. H. Frank and Dr. R. diMarchi, Lilly Research Laboratories 
(Indianapolis, IN). Wheat germ agglutinin (WGA) was from Vector 
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Laboratories (Burlingame, CA). Cyanogen bromide (CNBr)-Sepharose 4B 
beads were from Pharmacia Fine Chemicals (Piscataway, NJ). Aprotinin 
was from FBA Pharmaceuticals (New York). Bacitracin was from Pfizer 
(New York). y [32p )ATP was prepared from [32P]orthophosphate (lCN, 
Cambridge, MA) in Gammaprep vials (Promega Biotec, Madison, WI) as de-
scribed by the manufacturer. Electrophoresis reagents were from Serva 
(Heidelberg, Federal Republic of Germany) and the apparatus was from 
LKB Instruments, Inc. (Houston, TX). Autoradiography film, X-Omat AR 
was from Eastman Kodak Co. (Rochester, NY). Lightening + intensifying 
screens were from Dupont Co. (Wilmington, DE). All other reagents and 
chemicals were from Sigma Chemical Co. (St. Louis, MO) unless 
otherwise specified. 
Animals: Male Wistar (WI) BR rats (Charles River Laboratories, 
Wilmington, MA) weighing 100-160 g were allowed access to standard 
rodent chow and water ad libitum. Food was withdrawn -10 hours before 
experimentation with the exception of experiments using diabetic rats 
where controls and diabetics were allowed access to food ad libitum. 
Diabetes was induced with streptozotocin in citrate buffer, pH 4.5, 
administered intraperitoneally in a single dose of 120 mg/kg body 
weight to overnight fasted rats. Diabetic rats were studied 7 days 
after streptozotocin injection. For glucocorticoid studies, rats were 
injected daily at - 10:00 a.m. with a cortisone acetate suspension 
(Cortone, Merck Sharp & Dohme, West Point, PA) administered subcutane-
ously at a dose of 10 mg/100 g body weight for 5 days. This dose of 
cortisone results in plasma glucocorticoid concentrations similar to 
those observed in rats during severe stress (215). Control rats were 
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given an equal volume of saline. Glycosuria was monitored by TesTape 
(Eli Lilly Co.) and was 4+ in diabetic rats. Plasma glucose levels 
were determined with a Beckman Glucose Analyzer 2 (Beckman Instrument 
Co., Palo Alto, CA) on blood samples obtained when the animals were 
killed. Plasma insulin levels were measured by double antibody 
radioimmunoassay (83) using both rat insulin and human recombinant 
insulin as standards where appropriate. 
Insulin receptor isolation: For studies involving receptor 
activation in vitro, frozen muscles were powdered, homogenized and 
insulin receptors were solubilized and partially purified on YGA as 
described previously (29). For experiments involving in vivo 
activation, receptors were isolated by one of two methods as described 
previously (29,32) with minor modifications. In method A, frozen 
hindlimb muscles were powdered and homogenized in 50 roM Hepes l , pH 7.4, 
1% Triton X-100, 1 trypsin inhibitory unit/ml aprotinin, 5 mM EDTA, 10 
mM NaF, 10 roM sodium pyrophosphate, 1.5 mg/ml bacitracin, 100 uK Na3V04 
and 2 mM phenylmethy1su1fonyl fluoride. After centrifugation at 
10,000 x g for 10 min, the supernatant was centrifuged at 150,000 x g 
for 90 min. The supernatant was then applied to a YGA column pre-
equilibrated with 50 roM Hepes, pH 7.4, 0.1% Triton X-IOO, 5 mM EDTA, 10 
mM NaF, 10 roM sodium pyrophosphate and 100 uM Na3V04. The column was 
washed with 25 bed volumes of the same buffer and glycoproteins were 
eluted with this buffer supplemented with 0.3 M N-acetylglucosamine. 
This method was used in all experiments where the in vivo kinase 
activation assay was carried out using receptors adsorbed to insulin-
agarose beads. In method B, receptors were isolated as in method A 
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except that the WGA colunmn was washed with 50 mM Hepes, 0.1% Triton X-
100, 100 uK Na3V04, pH 7.4 and glycoproteins were eluted with this 
buffer supplemented with 0.3 M N-acetylglucosamine. Fo~lowing receptor 
isolation, WGA eluates were used within 24 hrs. This method was used 
in the experiments shown in Fig. 7, and was validated previously in our 
laboratory (32). All receptor preparations were separated into 
aliquots and stored frozen at -800 C until further use. 
Insulin binding: Insulin binding was performed as described 
previously (30) using A14[125I ] insulin (- 0.09 nM, 300 uCi/ug) without 
or with increasing concentrations of unlabeled insulin (1-10,000 
ng/ml). Binding at 10,000 ng/m1 unlabelled insulin was subtracted as 
nonspecific in all binding studies. All kinase assays were carried out 
using equal insulin binding activities from WGA eluates, determined by 
the ratio of specific binding between individual receptor preparations 
at several insulin concentrations as described previously (30). 
In vitro exogenous substrate kinase and autophosphorylation 
assays: For assays of kinase activity in vitro, two exogenous 
substrates were used: the synthetic copolymer poly glu-tyr (4:1) or 
histone H2b. For assays with poly glu-tyr, receptor preparations (- 25 
fmole insulin binding activity) were incubated without or with 
increasing concentrations of insulin (1 to 100 nM) in buffer containing 
50 roM Hepes, pH 7.4, 5mM MnC12' 12 roM MgCl2' 0.05% bovine serum albumin 
(BSA) and 3 mg/mi poly glu-tyr (4:1) for 45 min at 250 C. Samples were 
then chilled to 40 C. Phosphorylation was initiated by addition of 100 
uK Y [32p ]ATP (1 uCi/nmole). Reactions were allowed to proceed for 45 
min at 40 C and were stopped by addition of 50 roM unlabelled ATP. 
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Aliquots were spotted onto Whatmann 3MM filter paper and dropped into 
an ice cold solution of 10% trichloroacetic acid (TCA) and 10 roM 
Na4P207' Papers were then washed 3 times with 10% TCA 10 mM Na4P207 
at 250 C, dried, and 32p quantified by scintillation spectrophotometry. 
Samples without substrate were assayed in parallel and subtracted from 
samples with added substrate. A lag phase (- 10 min) was observed 
before exogenous substrate phosphorylation was linear; the lag phase 
was established to be identical for receptors from experimental groups 
and controls and presumably represents the time required for activation 
of the exogenous kinase at 40 C. For in vitro studies of B subunit 
autophosphorylation and exogenous kinase assays using histone H2b as 
the substrate, assay conditions were as described below for in vivo 
experiments, except that receptors (- 25 fmol) were incubated without 
or with 10- 7 M insulin instead of insulin agarose' prior to kinase 
assays and ATP concentration was 25 uK (25 uCijnmole). All experiments 
were performed under conditions where assays were linear with regard to 
receptor concentration and time. 
Assays of kinase activation in vivo: In the first set of experi-
ments control rats were anesthetized with methoxyfluorane (Me to fane , 
Pitman-Moore, Washington Crossing, N.J.) and injected via tail vein 
with saline or increasing doses of human insulin (Humulin, recombinant 
DNA origin, Eli Lilly, Indianapolis, IN). In subsequent experiments, 
control and diabetic, or control and cortisone acetate treated 
(glucocorticoid, GLX) rats were injected via tail vein with either 
saline or a single dose of insulin (0.10-0.11 Uj10a g or 5 Ujrat). 
Five min after injection, hindlimb muscles (gastrocnemius and soleus) 
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were frozen in situ with Wollenberger tongs precooled in liquid 
nitrogen and receptors isolated as decribed in the in vivo isolation 
procedure. Kinase assays were performed as described by Burant et ale 
(29,32) with minor modifications. In method A, receptors (- 100 fmole) 
isolated by the in vivo isolation method A were incubated for 20 min at 
25°C with insulin agarose (prepared as described by Yu and Czech, 
(303). Phosphatase and kinase inhibitors were then removed by washing 
once with buffer containing 50 roM Hepes, pH 7.4, 0.1% Triton X-lOO and 
50 roM NaCl, and then twice with buffer containing 50 roM Hepes, pH 7.4 
and 0.1% Triton X-100. 5 roM MnC12 , 0.05% BSA and Histone H2b (1 
mg/ml), were then added in buffer containing 50 roM Hepes, 0.1% Triton 
X-lOO, pH 7.4, and phosphorylation initiated with addition of 2.5 uK Y 
[32p]-ATP (50 uCi/nmole). This concentration of ATP is sufficient to 
support the transfer of phosphate from ATP to the substrate but is 
insufficient to further activate the receptor's exogenous kinase (303), 
thereby preventing activation in vitro. Reactions were allowed to 
proceed for 4 min at 250 C and stopped by the addition of 4X Laemm1i's 
sample buffer supplemen~ed with 5% 2-mercaptoethanol (final 
concentration). Samples were then placed in boiling water for 3 min. 
Proteins were separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) with a 5-19% polyacrylamide gradient. Gels 
were digested with 1 N NaOH at 55 0 C for 1 hour to hydrolyze serine 
and threonine phosphates (11). Histone H2B and the 8 subunit of the 
insulin receptor were localized by autoradiography, excised from dried 
gels, digested in 30% H202 and 32p counted by scintillation spectro-
photometry. An area of the gel determined to be free of 
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phosphoproteins, equivalent to the size of the excised bands was also 
excised, digested, counted and subtracted as background. 
In method B, receptors were isolated by the in vivo isolation 
method B. Receptors were incubated without or with 10-7M insulin in 
buffer containing 50 roM Hepes, pH 7.4, 0.1% Triton X-IOO, 5 roM MnC12, 
0.05% BSA and 100 uK Na3V04. Kinase assays were performed using 
histone H2b as substrate. Reaction conditions were identical to those 
described for the in vitro assays using this substrate. This allowed 
for the comparison of exogenous kinase activity after maximal 
activation in vitro with that obtained after maximal activation in 
vivo. 
All kinase assays were performed under conditions in which <10% of 
ATP was hydrolyzed. ATPase activity of individual receptor 
preparations was determined by measuring orthophosphate and ATP by high 
performance liquid chromatography before and after kinase assays as 
described previously (30). 
Others: Hindlimb muscle DNA was quantified using a modification 
of the Burton assay (281). Statistical analyses were performed by 
Students t test. 
RESULTS 
Animal characteristics: Table 1 summarizes the body weights, 
plasma glucose and plasma insulin levels of rats in all studies. Rats 
rendered diabetic by streptozotocin were markedly hyperglycemic and 
hypoinsulinemic and gained little or no weight over the 7 days. Rats 
injected with cortisone acetate either lost or failed to gain weight 
following the first day of injection. fasting plasma glucose and 
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insulin levels in cortisone treated rats were 236 ± 15 mg/dl and 81 ± 
11 uU/ml respectively, compared to a ~asting plasma glucose of 146 ± 7 
mg/dl and a fasting plasma insulin of 11 + 3 uU/ml in controls, 
indicating insulin resistance in the hypercortisolemic rats. 
Insulin binding to solubilized receptors: When subjected to 
Scatchard analysis (Fig 1) curvilinear plots were obtained with 
receptors from control and cortisone treated rats. No difference in 
the insulin binding affinity between the two groups was apparent. 
When expressed per g muscle, there appeared to be -30% increase in 
total number of receptors (by extrapolating to the X intercept of the 
curve) from cortisone treated rats as compared to controls. Since 
hypercortisolemia results in decreased muscle protein, we measured 
muscle DNA concentrations as an indication of muscle cell number. 
Hindlimb muscle (primarily gastrocnemius) DNA was significantly 
increased (851 + 49 ug/g muscle tissue) in cortisone treated rats-
compared to controls (662 ± 30 ug/g, n - 6 rats/group) (p < 0.01). 
Therefore, when receptor number was calculated per muscle cell, there 
was no difference in receptor number between cortisone treated rats and 
controls. There was an -2 fold increase in receptor number per g 
hindlimb muscle in diabetic rats compared to controls with no apparent 
change in insulin binding affinity confirming previous results (30) 
from our laboratory (data not shown). Hindlimb muscle DNA was also 
measured in control and diabetic rats. Hindlimb muscle DNA was 
significantly increased (880 + 52 ug/g muscle tissue) in diabetic rats 
compared to controls (650 + 20 ug/g, n = 6 rats/group) (p < 0.01). 
Therefore, when receptor number was calculated per muscle cell, it was 
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increased by - 50% in diabetic rats vs controls. No difference in 
number or insulin binding affinity was observed between receptors 
isolated from rat muscles 5 min after i.v. injections of insulin or 
saline (data not shown). 
In vitro autophosphorylation and exogenous substrate kinase 
activity of receptors isolated from control and cortisone treated rats: 
When receptors isolated from muscles of control or cortisone treated 
rats were incubated without insulin, very little 32p was incorporated 
into the Bsubunit of the receptors or into the exogenous substrate 
histone H2b. When incubated with insulin, a -4 fold increase in 32p 
incorporation into the 8 subunit of the receptor and histone H2b 
occurred with receptors isolated from muscles of control and cortisone 
treated rats. No significant difference in basal or insulin stimulated 
autophosphorylation (Fig. 2A) or H2b phosphorylation (Fig. 2B) was 
observed between receptors isolated from control rats or rats treated 
with cortisone. We also investigated whether similar results would be 
observed with another exogenous substrate, poly glu-tyr (4:1). Equal 
insulin binding activities of receptors isolated from control and 
cortisone treated rats were incubated without or with increasing con-
centrations of insulin (10. 9 - 10- 7 M). An insulin dose-dependent 
increase in incorporation of 32p into the synthetic substrate poly gIu-
tyr (4:1) was observed with receptors isolated from both control and 
cortisone treated rats (Fig. 3), with half maximal activation occuring 
at -1.3 X 10- 9 M insulin in both groups. The kinase activity towards 
this substrate was not significantly different between receptors 
isolated from control and cortisone treated rats at any insulin 
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concentration. 
Insulin dependent activation of the insulin receptor kinase in 
vivo: We examined whether insulin administration to the intact rat 
would result in dose-dependent activation of the muscle insulin 
receptor tyrosine kinase. A representative autoradiogram of 6 subunit 
autophosphorylation and H2b phosphorylation following saline or 
increasing doses of insulin (0.05, 0.1, 0.5, and 1 unit/IOO grams) i.v. 
is shown in Fig. 4. Insulin administration in vivo resulted in a dose-
dependent increase in the amount of phosphate incorporated into the B 
subunit of the receptor and into histone H2b although the effect of 
insulin was much greater on H2b than on the receptor. The results of 
H2b phosphorylation and B subunit autophosphorylation are summarized in 
Fig. SA and circulating insulin concentrations achieved at each dose of 
insulin are shown in Fig. SB. The phosphorylation of H2b is plotted as 
a function of circulating plasma insulin concentration in Fig. SC. 
Half maximal and maximal activation of the receptor exogenous kinase 
were observed 5 min after 0.1 and 0.5 U insulin/lOO g respectively cor-
responding to circulating plasma insulin concentrations of 7.9 ± 0.72nM 
and 84 + 8 oM respectively. These levels of insulin are approximately 
10 times higher than levels required for half maximal and maximal 
glucose transport in muscle in the intact rat (29). 
In vivo activation in control and cortisone treated rats: When 
kinase activity was assayed after adsorption of receptors to insulin-
agarose (in vivo method A) no significant difference in kinase activity 
towards H2b (Fig. 6A) or the B subunit of the receptor (Fig 6B) was 
observed between cortisone treated rats and controls at basal insulin 
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levels (after injection of saline) or after i.v. injection of a half 
maximally activating dose of insulin (0.1 U/lOO g). Circulating 
insulin concentrations 5 min after insulin injection were not 
significantly different between controls (6.0 + 0.53 oM) and treated 
(5.2 ± 0.52 riM) rats. 
In a separate set of experiments rats were injected with either 
saline or SU insulin/rat and in vivo kinase activity assessed by method 
B (Fig. 7). Using this method, we observed a significant increase in 
basal kinase activity (after saline injection) towards histone H2b of 
receptors isolated from cortisone treated rats, which presumably 
reflects their increased fasting plasma insulin concentrations (Table 
1) and the greater sensitivity of the assay. Again. no significant 
difference in kinase activity of receptors isolated from control or 
cortisone treated rats was observed after injection of insulin. 
Receptors fully activated with insulin in vivo were -90% active 
compared to the same receptors which were further activated with a 
maximally activating concentration of insulin in vitro (Fig 7) similar 
to previous reports from our laboratory (7). Similar results were 
obtained using poly glu-tyr (4:1) as substrate (data not shown). 
There was no significant difference in the amount of phosphate incor-
porated into the 8 subunits of the receptors isolated from control or 
cortisone treated rats using this method (data not shown). 
In vivo activation in control and diabetic rats: Saline, or a 
half maximally activating dose of insulin (0.1 U/lOO g) or a 
supramaximally activating dose of insulin (5 U/rat) was injected via 
tail vein to control or diabetic rats. A representative autoradiogram 
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of histone H2b and e subunit phosphorylation after a half maximally 
activating dose of insulin in vivo is shown in Fig. 8. Quantification 
of results obtained with both doses of insulin is shown in Fig. 9. 
Receptors isolated in their activated state from diabetic rats showed a 
significant, S2% (p < 0.01) or 40% (p < 0.05), decrease in kinase 
activity toward H2b 5 min after i.v. insulin administration of 0.1 
U/100g or SU/rat respectively compared to receptors isolated from 
insulin treated controls (Fig. 9A). In vitro phosphate incorporation 
into the B subunit of the receptor was also significantly lower in 
receptors isolated from diabetic rats compared to controls after 
exposure to insulin in vivo. Receptors isolated from diabetic rats 
incorporated 44% (p < 0.01) or 60% (p < 0.025) less phosphate than 
equal numbers of insulin receptors isolated from controls after i.v. 
insulin administration of 0.1 U/lOOg or SU/rat respectively (Fig 9B). 
No significant difference in kinase activity towards histone H2b or 
phosphate incorporated into the B subunit was observed between recep-
tors isolated from the two groups at basal insulin levels. Circulating 
plasma insulin concentrations were not significantly different between 
control (7.9 + 2.1 riM) and diabetic (7.6 + 2.0 tiM) rats after injection 
of the half maximally activating dose. After injection of the 
supramaximally activating dose, circulating insulin concentrations were 
significantly higher in diabetic (444 ± 52 riM) vs. control (238 ± 8 nM; 
P < 0.025) rats, because all rats received the same amount of insulin 
and the diabetics weighed less than controls (Table 1). Since the 
differences in insulin receptor tyrosine kinase activities observed in 
these assays could have been due to variability in the proportion of 
47 
receptors adsorbed to the insulin-agarose, binding assays were 
performed on the supernatants after adsorption. Less than 5% of the 
receptors added to the insulin agarose were recovered in the 
supernatants with no significant difference between control and 
diabetic derived receptors. 
DISCUSSION 
Insulin receptor tyrosine kinase activation occurs in response to 
insulin in purified receptor preparations (95,303), and in vivo 
(29,32,95,143). An insulin dose-dependent activation of the insulin 
receptor kinase has been established in solubilized receptors and in 
isolated intact adipocytes (143). Studies in our laboratory reported 
activation of the muscle insulin receptor kinase in intact rats 
following a single bolus injection of insulin i.v. (29,32). In the 
present study we further demonstrate that the muscle insulin receptor 
tyrosine kinase is activated in a dose-dependent manner following· 
insulin administration in the intact rat. In our system, half maximal 
and maximal activation of the muscle insulin receptor tyrosine kinase 
in the intact rat occured at circulating insulin levels of -8 X 10- 9 M 
and -8.7 X 10- 8 M respectively. These are ~10 and -20 fold higher than 
levels which result in half maximal and maximal glucose transport in 
muscles of intact rats using the euglycemic clamp technique (152) and 
in isolated rat solei (159) respectively. Glucose transport is not 
directly coupled to receptor occupancy in rat soleus muscle (159) 
indicating that muscle contains spare receptors. This may explain the 
discrepancy between in vivo glucose transport and in vivo kinase 
activation in muscle, as it has been shown in Fao hepatoma cells (95) 
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and isolated adipocytes (143), that insulin receptor autophosphoryla· 
tion and exogenous substrate kinase activation correlates more closely 
with receptor occupancy than with the concentration of insulin which 
elicits biological effects. In muscle, half maximal binding to 
isolated solei occurred at insulin levels of 10. 8 M (159,302) and 4 X 
10 -9 M (94) which are close to the levels which we report for half 
maximal· activation of the muscle insulin receptor kinase in vivo. 
However, caution must be taken in attributing our results solely to the 
existence of spare receptors because in euglycemic clamp experiments 
samples are taken after the first hour of insulin infusion (152). Our 
observation that supraphysiological levels of insulin were necessary to 
fully activate the receptor after a 5 min bolus could be due to lack of 
sufficient time for equilibrium binding of insulin. Recently, 
significant activation of the muscle insulin receptor kinase at 
physiological levels of insulin was reported using euglycemic clamp 
techniques in rats (26), with half maximal activation at 330 uU/ml 
(-2.1 X 10- 9 M) insulin. Also, insulin's effects .can be potentiated by 
a prior insulin exposure. In rat epitrochlearis muscle exposed to 
supraphysiologic levels of insulin (20,000 uU/ml, -1.25 X 10- 7 M), 
maximal glucose transport was obtained in 15 min whereas a similar rate 
of transport was achieved at a physiological level (50 uU/m1, -3.1 X 
lO-lOM) only after a much longer exposure time (301). Similarly, 
higher rates of glucose transport are achieved over time in euglycemic 
clamp studies (152,301). Therefore whether the lower dose of insulin 
required for half-maximal activation of the insulin receptor kinase 
using the clamp technique reflects equilibrium binding or a 
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potentiating effect of long exposure to insulin is unknown. Since in 
isolated adipocytes, internalized activated receptors are dephos-
phorylated more rapidly than non-internalized activated receptors 
(144), we killed the rats 5 min after insulin injection to minimize 
internalization and therefore possible dephosphorylation of the insulin 
receptor after activation (in adipocytes t 1/2 for receptor inter-
nalization is < 10 min (146». 
Autophosphory1ation of the receptor was still detectable in our in 
vivo assay even though we utilized conditions which we had previously 
determined did not activate the receptor's exogenous kinase (29,32 and 
data not shown). Phosphorylation of the receptor can occur without 
activation if conditions prohibit phosphorylation of critical sites on 
the receptor (32,143,303). Autophosphorylation in this assay may 
reflect the S subunits of the receptors serving as in vitro substrates 
for the in vivo activated receptor. Whether this occurs intra- or 
intermolecu1ar1y or both is not known. Quantitatively however, the 
insulin effect on phosphate incorporation into histone-H2b was greater 
than on the in vitro 8 subunit phosphorylation in the "in vivo 
activation" assay. Autophosphorylation was detectable even after the 
receptor was maximally activated in vivo. This is similar to what 
occurred in isolated adipocytes (143) and suggests that certain tyro-
sines on the receptor which seem not to be required for activation, are 
not accessible in vivo but can be phosphorylated in vitro. 
Insulin receptor kinase activity has been shown to be decreased in 
receptors solubilized from muscle (30) and liver (123,195) of rats 
rendered diabetic with streptozotocin. Studies of other insulin 
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resistant states including patients with NIDDM (34 t 78) obese humans 
(35) and obese rats (158) have reported similar decreases in exogenous 
kinase activity of solubilized muscle (35,158), adipose tissue (78) and 
liver (34) receptors after insulin binding in vitro. Note however, 
that discrepant observations have also been reported in several of the 
conditions listed above (discussed in 30,35,87). In the streptozotocin 
diabetic rat model, insulin receptor autophosphorylation was also 
reported to be increased (17) or unchanged (4,272) in solubilized 
receptors from liver (4 t 17) and adipocytes (272). Furthermore, 
exogenous kinase activity towards the substrate poly glu-tyr (4:1) was 
unaltered (272) in receptors solubilized from insulin resistant 
adipocytes from streptozotocin diabetic rats. The reason(s) for these 
discrepancies are not clear. In addition to possible methodological 
differences in receptor preparation, variables include the use of 
different tissues, differences in the duration or degree of diabetes 
and the use of different substrates to measure exogenous kinase 
activity as discussed below. 
Metabolic effects on the insulin receptor may be tissue specific. 
Altered insulin receptor kinase activity has been reported in obese 
humans without or with NIDDM, but the effects varied with the type of 
tissue studied. Caro et a1. (34) and Freidenberg et a1. (78) reported 
mild (34) or no (78) effects of obesity on the kinase activity of liver 
or adipocyte derived receptors while insulin receptors derived from 
skeletal muscle (35) of similar obese patients were resistant to 
exogenous tyrosine kinase activation by insulin. In addition, the 
tyrosine kinase activity of insulin receptors derived from liver or 
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adipocytes of obese patients with NIDDM was decreased when compared to 
obese patients without NIDDM (34,78) while this was not observed in 
receptors derived from skeletal muscle (35). Insulin resistance has 
been related to the duration of the insulinopenia in rats (178) and to 
the degree of control of diabetes in humans with IDDM (30). It is 
therefore possible that the time after induction of diabetes or 
differences in the severity of the metabolic alterations elicited by 
different research protocols affect the observed receptor kinase ac-
tivities. In studies of liver derived insulin receptors Blackshear et 
a1. (17) reported increased autophosphorylation of the insulin receptor 
48 hours after administration of streptozotocin; Amatruda et al. (4) 
reported no effect on the kinase 7-21 days after streptozotocin 
treatment which resulted in nonketotic diabetes; Okamoto et a1. (195) 
on the other hand, found decreased exogenous kinase activity 5 weeks 
following induction of diabetes and furthermore, found a larger 
decrease in severely diabetic rats compared to mildly diabetic rats. 
The rats which we studied were severely diabetic indicated by 
undetectable insulin levels and no weight gain. Finally, laboratories 
examining exogenous kinase activity of diabetic derived insulin 
receptors compared to controls used different substrates as 
phosphoacceptors. Substrate specific effects have already been 
reported in some insulin resistant states since decreases in exogenous 
substrate kinase activities have been observed without concomittant 
decreases in receptor autophosphorylation (34,35,78,79). This under-
scores the need for defining the endogenous substrate(s) of the insulin 
receptor kinase and examining their rec~ptor mediated phosphorylation 
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in insulin resistant states. 
It has been suggested that defective tyrosine kinase activity may 
contribute to insulin resistance although insulin receptor tyrosine 
kinase activation in vivo had not been previously investigated in any 
of these conditions. Our results indicate that following induction of 
streptozotocin diabetes in rats, activation of the muscle insulin 
receptor kinase is impaired upon insulin binding in vivo. These 
results, therefore, further support the hypothesis that altered insulin 
receptor kinase activation could contribute to the insulin resistance 
observed in severe, uncontrolled insulinopenic diabetes. Since the 
number of receptors per muscle cell was increased - 50% in rats with 
insulinopenic diabetes, the reduction in kinase activity per receptor 
may have limited biological significance if phosphorylation of the 
endogenous substrate(s) of the insulin receptor kinase parallels that 
of the model substrate used. The answer to these questions awaits 
definition of the endogenous substrate(s) of the insulin receptor 
tyrosine kinase. 
Our in vivo assay utilizing adsorption to insulin agarose did not 
detect differences in basal kinase activity between control and 
diabetic rats or between control and glucocorticoid treated rats 
despite the fact that circulating basal insulin levels were nearly 
undetectable in diabetics and were nearly twice as high in cortisone 
treated rats compared to controls. This is probably due to limitations 
in the sensitivity of this assay and the relatively large variance of 
measurement. When assayed without adsorption to the beads, we did 
detect a small but significant increase in basal kinase activity of 
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receptors isolated from glucocorticoid treated rats compared to con-
trols. Using both methods, there was no significant difference in 
kinase activation by exogenously administered insulin. Our results 
indicate that in vivo administration of cortisone to rats has no 
significant effect on insulin receptor number or insulin binding 
affinity of solubilized muscle insulin receptors. Similarly, cortico· 
sterone· in vitro did not affect insulin binding to mouse solei (265). 
In a number of tissues increased circulating insulin results in down 
regulation of the insulin receptor while decreased circulating insulin 
levels result in up-regulation of the the insulin receptor 
(30,123,195). It is interesting that despite increased circulating 
insulin levels, the total number of receptors isolated from muscles of 
cortisone treated rats was not decreased compared to controls. Ad-
ministration of glucocorticoids to rats results in depressed insulin 
binding in adipocytes and hepatocytes (199) presumably due to down 
regulation caused by increased circulating insulin levels, or as 
suggested in studies of rat liver membranes due to decreased insulin 
binding affinity with no change in receptor number (128). In 
preliminary studies we found a decrease in the number of insulin 
receptors isolated from liver in the same rats in which no change in 
insulin receptor number was found in muscle (data not shown). Dexa-
methasone stimulates the synthesis of insulin receptors in IM9 
lymphocytes (72) and in cultured rat hepatocytes (234) and increases 
insulin receptor mRNA in IM9 lymphocytes (176). Chronic exposure of 
3T3 mouse fibroblasts to dexamethasone results in increased receptor 
number due to decreased receptor degradation with no change in receptor 
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synthesis (145). Thus, any down regulation due to increased 
circulating insulin levels could be offset in muscle by possible 
effects of glucocorticoids on receptor synthesis and/or degradation. 
Since glucocorticoids affect mUltiple insulin sensitive pathways 
in muscle: glucose transport, amino acid transport, protein synthesis 
and protein degradation, we postulated that excess glucocorticoids may 
exert their effects by modulating insulin receptor tyrosine kinase 
activation. In the present study under conditions, where 
glucocorticoid induced insulin resistance was quite evident, there was 
no detectable impairment of muscle insulin receptor tyrosine kinase 
activation. Our results are in agreement with those of Truglia et a1. 
(72) who found no effect of dexamethasone administration to rats on the 
autophosphorylation of the insulin receptor in situ or on the exogenous 
kinase activity of receptors solubilized from insulin resistant 
adipocytes. Whether or not glucocorticoids in combination with other 
factors may contribute to the insulin receptor tyrosine kinase defect 
observed in some conditions is unknown. Our data suggests that in 
muscle the insulin resistance associated with glucocorticoid excess is 
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Figure 1. Scatchard plot of 125I-insulin binding to solubilized, 
WGA-purified insulin receptors. WGA eluates (25 ul) from skeletal 
muscle of control or cortisone treated (GLX) rats were incubated with 
trace A14[l25 I ]insulin in a total volume of 200 ul, with buffer 
containing 50 mM Hepes, 100 mM NaCl, 0.05 mg/ml bovine serum albumin, 
0.1% Triton X-lOO and 0.075 M N-acetylglucosamine, pH 7.8, for 16 h at 
4°C. The receptor and bound insulin were precipitated by sequential 
addition of 100 ul of 0.3% bovine gamma globulin and 300 ul of 25% 
polyethylene glycol. Radioactivity precipitated in the presence of 
10,000 ng/ml unlabeled insulin was subtracted from each point as 
nonspecific binding. Binding data were normalized to weight of tissue 
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Figure 2. Autophosphorylation (A) and histone kinase activity (B) 
of solubilized insulin receptors activated in vitro. Equal insulin 
binding activities of receptors from control or cortisone tre~ted (GLX) 
rats were incubated with histone H2b, without or with lO-7M insulin as 
described under "Materials and Methods". Phosphorylation was initiated 
by addition of 25 uM y[32p ]ATP (25 uCi/nmole) and after 4 min at 2SoC 
reactions were stopped by addition of 4 times concentrated Laemmli's 
sample buffer. Samples were separated by SDS-PAGE and after hydrolysis 
of stained gels with 1 N NaOH for 1 hr at 55°C, 8 subunit and histone 
bands were localized by autoradiography. After excision of bands 
radioactivity was determined by scintillation spectrometry. Values are 
means + SE for three different receptor preparations. 
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Figure 3. Dose response of poly glu-tyr (4:1) kinase activity of 
solubilized insulin receptor activated with insulin in vitro. Equal 
insulin binding activities of receptors isolated from muscles of 
control and cortisone treated (GLX) rats were incubated at 250 C with 
poly glu-tyr (4:1) without or with increasing concentrations of insulin 
(10- 9 - lO-7M) in buffer containing 5 mM MnC12 and 12 mM MgCl2, 50 mM 
Hepes, 0.1% Triton X-100, 0.05% BSA, pH 7.4 as described under 
"Materials and Methods". Phosphorylation was initiated by addition of 
100 uM y[32p ]ATP (1 uCi/nmole) and reactions stopped after 45 min at 
4°C by addition of 50 mM unlabelled ATP. Aliquots were spotted onto 
Whattman 3MM paper, precipitated by an ice cold solution of 10% TCA, 10 
roM Na4P207 and washed as described under "Materials and Methods". 
Radioactivity on papers was determined by scintillation spectrometry. 
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Figure 4. Autoradiogram of 8 subunit and histone H2b phosphory-
lation by receptors solubilized after activation with insulin in vivo. 
Control rats were anesthetized and injected with saline or increasing 
doses of insulin (.OS - 1.0 U/lOO g) via tail vein and receptors were 
isolated after 5 min in their in vivo activation state (method A) as 
described in ftMaterials and Methods". Equal insulin binding activities 
of receptors were adsorbed to insulin-agarose and washed as described 
in "Materials and Methods". After addition of 1 mg/ml histone H2b, and 
S mM MnC12 in a buffer containing 50 mM Hepes, 0.1% Triton X-lOa 0.05% 
BSA pH 7.4, kinase reactions were initiated by addition of 2.5 uK Y 
[32 p ]ATP (50 uCi/nmole) and stopped after 4 min at 2SoC by addition of 
4 times concentrated Laemmli's sample buffer. Samples were then 
separated by SDS-PAGE, and gels were hydrolyzed with 1 N NaOH at 5SoC 
for 1 hr. 8 subunit and H2b bands were localized by autoradiography of 
dried gels. The single arrow indicates the 8 subunit band and the 
double arrows indicate the location of histone H2b. 
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Figure 5. Histone H2b and 8 subunit phosphorylation by receptors 
activated with insulin in vivo. Anesthetized control rats were 
injected with increasing doses of insulin via tail vein. Five min 
after injection t receptors were isolated and kinase assays performed as 
described in legend to Fig. 4. After autoradiography, B subunit and 
histone H2b bands were excised from gels and radioactivity was 
determined as described in "Materials and Methods". A. Kinase 
activity towards histone H2b and B subunit phosphorylation as a 
function of insulin dose. B. Circulating plasma insulin con-
centrations as a function of insulin dose. C. Kinase activity towards 
histone H2b plotted as a function of circulating plasma insulin 
concentration. Insulin doses were 0, 0.05, 0.1, 0.5 and 1.0 U/100 g 
which corresponds to doses of 0, 1923, 3846, 19,230 and 38,460 ng/100 g 
respectively (1 ng - 26 uU). Each point is the mean ± SE for 4 rats. 
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Figure 6. Effect of cortisone treatment on insulin receptor 
activation by a half maximally activating dose of insulin in vivo. 
Control or cortisone treated (GLX) rats were injected with saline or a 
half maximally activating dose of insulin (0.10 - 0.11 U/100 g) via 
tail vein. Five min after injection receptors were isolated and their 
in vivo kinase activity measured as described in legend to Figs. 4 and 
5. A. Kinase activity towards histone H2b. B. Phosphate 
incorporated into the B subunit of the insulin receptor. Values are 
means + SE for 8-9 rats/group. 
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Figure 7. Effect of cortisone treatment on insulin receptor 
activation by a supramaximally activating dose of insulin in vivo. 
Control or cortisone treated (GLX) rats were injected with saline or SU 
insulin via tail vein and receptors were isolated after S min in their 
in vivo activation state (method B) as described in "Materials and 
Methods". Equal insulin binding activities of receptors were incubated 
without or with 10- 7M insulin, in buffer containing 5 mM MnCl2, O.OS% 
BSA, 50 mM Hepes, 0.1% Triton X-IOO and 100 uK Na3V04, pH 7.4 for 20 
minutes at 25 0 C. After incubation for 10 min. at 2SoC with H2b (0.4 
mg/ml), phosphorylation was initiated by addition of 25 uM Y [32p ]ATP 
(25 uCi/nmole) and after 4 min at 2SoC reactions were stopped by 
addition of 4 times concentrated Laemmli's sample buffer. Samples were 
separated by SDS-PAGE and after hydrolysis of stained gels with IN 
NaOH for 1 hr at 55°C, histone bands were localized by autoradiography 
of dried gels. After excision of bands radioactivity was determined by 
scintillation spectrometry. £ach point is the mean + SE for 4 rats. 


























Figure 8. Autoradiogram showing a subunit and histone H2b 
phosphorylation by receptors isolated from control or diabetic rats 
after activation with a half maximally activating dose of insulin (0.1 
UllOa g) in vivo. The single arrow indicates the a subunit band and 













Figure 9. Effect of diabetes on insulin receptor activation in 
vivo. Anesthetized control or diabetic rats were injected with saline 
(0), a half maximally activating dose (0.1 U/100 g), or a 
supramaximally activting dose (5 U/rat) of insulin via tail vein. Five 
min after injection, receptors were isolated in their in vivo 
phosphorylated state and kinase activity measured as described in the 
legends to Figs. 4 and 5. A. Kinase activity towards histone H2b. B. 
Phosphate incorporated into the 8 subunit of the insulin receptor. 
Values are means + SE for 3-5 rats/group. *p < 0.05 vs control. 
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CHAPTER III 
KINETICS OF THE HEPATIC INSULIN RECEPTOR TYROSINE KINASE: 
EFFECTS OF SUBSTRATE INHIBITION AND DIABETES 
INTRODUCTION 
Insulin resistance is associated with uncontrolled insulinopenic 
diabetes in humans (58,155,173,203) and in experimental models of 
insulinopenia (155). Diminished in vivo glucose disposal (58), 
decreased glucose transport (27,133,277,278,307) and decreased activi-
ties of insulin sensitive intracellular enzymes (1,2,9,18) are observed 
in isolated skeletal muscle (9,277,278), hepatocytes (2,181) and 
adipose tissue (272) despite normal to increased insulin binding. 
Insulin binding to the a subunits of the insulin receptor initiates a 
cascade of autophosphorylation on tyrosine residues of the a subunits. 
Progression of the cascade to critical sites results in activation of 
the insulin receptor's exogenous tyrosine-specific kinase. The 
necessity of insulin receptor autophosphorylation and exogenous kinase 
activity for insulin's coupling to its cellular effects has been esta-
blished by several investigators with the use of specific antibodies 
against, or by site directed mutagenesis of the a subunit which block 
insulin stimulation of metabolic events (Reviewed in 225). 
Our laboratory and others have shown that autophosphorylation 
and/or activation of the insulin receptor tyrosine kinase isolated from 
skeletal muscle (30) and liver (85,123,195) of rats rendered diabetic 
with streptozotocin (STZ) , is impaired after insulin binding in vitro 
or in vivo. In liver (123) the defect correlated with the severity of 
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diabetes and in muscle (30) and liver (195) it could be reversed with 
chronic insulin replacement. These studies suggested that impaired 
receptor activation may contribute to the insulin resistance observed 
in uncontrolled IDDM. However, others reported no effect of STZ 
diabetes on autophosphorylation or exogenous kinase activity in liver 
(4,85) or adipose tissue (272) measured in vitro (4,85) or in situ 
(272). The discrepancies have been ascribed to differences in the 
study protocols (4,18,85) although none have been experimentally 
addressed. 
Several endogenous substrates for the insulin receptor tyrosine 
kinase have been demonstrated in intact cells, however their identity 
and/or role in the signalling process is unknown (1,14,16,97,112, 
167,124,232,289). Therefore most studies rely on the use of various 
exogenous phosphoacceptors to examine insulin receptor tyrosine kinase 
activity in vitro. Many of these are excellent substrates for the 
activated receptor but at levels above their Km, can also inhibit 
activation of the insulin receptor kinase (23,148,156,233,248). It is 
not known whether substrate inhibition contributes to altered kinase 
activities observed with receptors isolated from insulin resistant 
tissues, even though the conditions used may involve inhibition by 
these substrates (4,85). 
The native structure of the insulin receptor is believed to be the 
S-a-~-S tetramer linked by disulfide bonds (53). However, a·a dimers 
have been isolated from liver membrane preparations without the use of 
reducing agents (147,169). Since a-a dimers generated experimentally 
by reducing agents possess decreased insulin stimulated autophosphory-
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lation and exogenous kinase activity compared to intact tetramers 
(20,260) differences in insulin receptor kinase activity observed 
between receptors isolated from diabetic and control rats may be due to 
the prevalence of dimers. 
The present study was designed to address three questions: 1.) 
Does substrate inhibition play a role in the differences in exogenous 
kinase activity observed between receptors isolated from livers of 
control and STZ-diabetic rats? 2.) Are the effects of STZ diabetes on 
insulin receptor kinase activity expressed differently towards differ-
ent substrates? 3.) Is the proportion of a-a insulin receptor dimers 
increased in livers of rats with streptozotocin-induced diabetes? 
MATERIALS AND METHODS 
Materials: Streptozotocin was a gift from Upjohn Research 
Laboratories (Kalamazoo, MI). Mono component, crystalline pork insulin 
was a gift from Dr. Ronald Chance and monoiodinated Al4 125I-insulin 
from Dr. B. H. Frank and Dr. R. diMarchi, Lilly Research Laboratories 
(Indianapolis, IN). Polyclonal antiinsulin receptor antibody P5 was a 
gift from Dr. Ora M. Rosen, Memorial Sloan-Kettering Cancer Center (New 
York, NY). Histone H2b was from Worthington Biochemicals (Freehold, 
NJ) Protein-A-bearing Staphylococcus aureus (Pansorbin) from Calbio-
chem-Behring (Los Angeles, CA) was treated before use with 2-mercapto-
ethanol. Wheat germ agglutinin (WGA) was from Vector Laboratories 
(Burlingame, CA) .. Aprotinin was from FBA Pharmaceuticals (New York, 
NY). [y_32p ]ATP was prepared from [32P]orthophosphate (lCN t Cambridge, 
MA) in Gammaprep vials (Promega Biotec, Madison, WI) as described by 
the manufacturer. Electrophoresis apparatus was from LKB Instruments 
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(Houston, TX). Reagents for electrophoresis were from Serva (Heidel-
berg, FRG). X-Omat AR Autoradiography film was from Eastman Kodak 
(Rochester, NY). Centricon 10 and 30 miniconcentrators were from 
Amicon (Danvers t MA). Sepbadex G-50 was from Pharmacia (Piscataway, 
NJ). Bio-Gel A was from Bio-Rad (Richmond, CA). All other reagents 
were from Sigma Chemical (St. Louis, MO). 
Animals: Male wistar BR rats (Charles River Laboratories, 
Wilmington, MA) weighing 100-180 g were allowed access to standard 
rodent chow and water ad libitum. Diabetes was induced with streptozo-
tocin in citrate buffer, pH 4.5, by a single intravenous dose of 
100-120 mg/kg body wt to overnight fasted rats. Rats were studied 2-3 
weeks following induction of diabetes. Only diabetic rats with 4+ 
glycosuria, measured by Tes Tape (Eli Lilly) and minimal or no weight 
gain were used. Livers were extracted from animals for isolation of 
insulin receptors after anesthesia with Methoxyfluorane (Metofane, 
Pitman-Moore, Washington Crossing, NJ). 
Insulin receptor purification: Livers (-1 g) from anesthetized 
control or diabetic rats were rapidly frozen in liquid nitrogen and 
insulin receptors were solubilized and partially purified by WGA 
affinity chromatography as described previously (18), with minor 
modifications. Tissues were powdered and homogenized at 4°C in 50 mM 
N~2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.4, 
1.5% Triton X-100, 1 trypsin inhibitory unit/ml of aprotinin, 5 roM 
EDTA, 1.5 mg/ml bacitracin, 1 mg/ml benzoyl arginine ethyl ester 
(BAEE), 1 mg/ml tosyl arginine methyl ester (TAME), 1 mg/ml 
benzamidine, 3 ug/ml leupeptin, and 2 roM phenylmethylsulfonyl fluoride 
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(PMSF). Following centrifugation at 4°C, 10,000 g for 10 min, the 
supernatant was centrifuged at 150,000 g for 90 min at 4°C. The 
supernatant was then cycled 3 times over a YGA column (-2 ml) 
preequi1brated with 50 roM HEPES, pH 7.4, 0.1% Triton X-100 at 25°C. 
After washing the column with 100 m1 of the same buffer, glycoproteins 
were eluted with this buffer supplemented with 0.3 M N-
acetylg1ucoasamine. YGA eluates were then aliquoted and stored frozen 
at -70°C until use. 
Insulin binding: Equilibrium insulin binding with A-l4 125I-Insu-
lin and unlabelled insulin, followed by PEG precepitation of insulin 
receptor complexes was performed as described previously (30). Equal 
insulin binding activities in YGA eluates from control and diabetic 
liver for use in kinase assays was determined by ratios of binding at 
several insulin concentrations as described previously and at 2 WGA 
eluate concentrations. 
Exogenous substrate kinase assays: Two exogenous substrates were 
used: histone H2b or the synthetic polymer, poly (Glu-Tyr) (4:1). For 
assays with histone H2b, equal insulin binding activities of control 
and diabetic liver (-10 - 50 fmoles) were incubated without or with 
10- 7 M insulin in buffer containing 50 roM HEPES, pH 7.4, 0.1% Triton X-
100, 0.05% bovine serum albumin (BSA) and 5 roM MnCl2 at 4°C for 16 h. 
To examine the effects of substrate inhibition samples were then 
incubated without or with increasing concentrations of H2b (0.2 - 1000 
ug/ml) at 250 C for 10 min. Phosphorylation was then initiated by the 
addition of y_[32p ]ATP (25 uCi/nmo1, concentrations indicated in figure 
legends) and 100 uM Na3V04, and reactions were allowed to proceed for 4 
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min at 25°C. In some experiments phosphorylation was initiated before 
the addition of R2b with 100 uM. 01: 25 u.M." \. 32~\~i."i? an.d. con.t:.i.n.ue.d £01: 4. 
min at 25°C or 30 min. at 4°C, respectively when H2b (40 - 1000 ug/ml) 
was added. Reactions were then allowed to proceed for an additional 4 
min at 25°C or 20 min. at 4°C respectively. All reactions involving 
H2b were stopped by the addition of four times concentrated Laemmlits 
sample buffer supplemented with 5% 2-mercaptoethanol (final concentra-
tion), followed by boiling for 3 min, with subsequent separation of 
proteins by sodium dodecy1 sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) using a 5-19% polyacrylamide gradient. To hydrolyze serine 
and threonine phosphates and enrich for phosphotyrosine, stained gels 
were digested with 1 N NaOH at 55°C for 1 h. Histone H2b and the a -
subunit of the insulin receptor were localized by autoradiography, 
bands were excised and digested in 30% H202 and 32p quantified by 
scintillation spectrophotometry. An area of the gel, free of phos-
phoproteins, equivalent, to the size of the excised bands was excised, 
digested, counted and subtracted as background. 
For assays with poly (Glu-Tyr) 4:1, equal insulin binding activi-
ties (-SO fmoles) of WGA eluates from control and diabetic livers were 
incubated without or with insulin as described in the figure legends in 
buffer containing SO roM HEPES, pH 7.4, 2 roM MnCI2, 10 roM MgCl2' and 
0.05% BSA at 4°C for 16 hr. Substrate was then added in the concentra-
tions indicated in the figure legends. After 10 min at 25°C, phos-
phorylation was initiated by addition of 25 uM [y.32p ]ATP (10 uCi/nmol) 
and 100 uM Na3V04, and was stopped after 4 min at 25°C by the addition 
of 50 roM unlabelled ATP. Samples without substrate were assayed in 
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parallel for use as background. Samples were then spotted onto Whatman 
3MM filter paper, precipitated, washed and counted as described 
previously (18). 
All kinetic assays were performed on one pair of control and 
diabetic receptor preparations in each experiment. All kinase assays 
involving exogenously added substrates were performed under conditions 
which were determined to be linear with regards to time and WGA eluate 
concentration from diabetic and control liver. Kinase assays were 
performed under conditions in which ATPase activity was determined 
previously to be undetectable. ATPase activity was determined by 
separation of Pi and ATP before and after kinase assays by high 
pressure liquid chromatography as described previously (30). 
Autophosphorylation: Autophosphorylation reactions were carried 
out under identical conditions as described for exogenous kinase assays 
involving histone H2b, with the exception that in some assays, reac-
tions did not include H2b. 
Immunoprecipitation: Immunoprecipitation of insulin receptors 
bound to l25I-insulin by anti-PS (1:100 antibody dilution) was carried 
out with equal insulin binding activities of WGA eluates from diabetic 
and control liver as described previously (32) except that NaCl 
concentration was 150 roM and PMSF was not included in the buffer. 
Preparation and isolation of dimers: Dimers were prepared as 
described previously by Sweet et a1. (259) with minor modifications. 
WGA eluates from control liver were concentrated with Centricon 30 
miniconcentrators to a protein concentration of 1.5 ug/m1, adjusted to 
pH 8.5 with 1.0 M Tris and incubated a~ 2SoC for 25 min. Dithio-
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threito1 (2 roM, OTT) was then added for 5 min at 250 C followed by 
immediate separation of samples from OTT by gel filtration at 40 C on a 
Sephadex G-50 column preequilibrated with buffer containing 50 roM Tris, 
pH 7.6, 150 roM NaCl, 0.1% BSA, 0.1% Triton X-lOO and 0.02% NaN3-
Alternatively, YGA eluates were incubated overnight at 40 C with 2 roM 
DTT and then separated from OTT as described above. Samples were then 
concentrated using Centricon 30 miniconcentrators and resuspended in 
buffer containing 10 roM Tris, pH 7.6, 150 roM NaCl, 0.1% Triton X-lOO 
and 0.02% NaN3 (column buffer) supplemented with 0.1% BSA, and 
subjected to gel filtration on a Bio-Gel A 1.5 M column (2.7 cm x 60 
cm) preequilibrated with column buffer supplemented with 0.1% BSA. YGA 
eluates from control and diabetic liver were also treated as described 
above except without the addition of OTT. Molecular weight standards, 
Blue Dextran (Vo) , Ferritin (440K), Myosin (20SK) and Phosphorylase B 
(97.4K) were run in column buffer in parallel on a column 
preequilibrated with column buffer. 
Detection of dimers and tetramers: Bio-gel eluate fractions (0.4 
m1) were collected and each incubated for 16 hr at 40 C with l25I-Insu-
lin (10. 11 M) without or with 10.6 M unlabeled insulin in buffer 
containing 50 mM HEPES, 0.1% Triton X-lOO, 0.1% BSA, 150 mg/ml bacitra-
cin (binding buffer); and either 10 roM NaCl (low salt), pH 7.0 or 150 
roM NaCl (high salt), pH 7.6 to optimize for insulin binding by dimers 
and tetramers, respectively. Following equilibrium insulin binding, 
samples were analyzed by one of two methods: In the first method, 
insulin-receptor complexes were precipitated by standard PEG precipita-
tion as described previously (30). In the second method insulin was 
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crosslinked to its receptor with 2 roM dissuccinimidyl suberate (DSS) as 
described previously (30). Radioactivity in samples precipitated with 
PEG was quantified in a gamma counter. Proteins in samples crosslinked 
with DSS were separated by nonreducing SDS-PAGE with a 4-10% linear 
polyacrylamide gradient, after addition of 15 roM N-ethylmaleimide (NEM) 
and Laemmli's sample buffer. Labelled bands were identified by autora-
diography of stained, dried gels. Fractions from columns with molecu-
lar weight standards were analyzed by UV absorbption at 280 nm with a 
spectrophotometer. 
Histone binding to ATP: 25 uK ATP, in the absence or presence of 
5 roM MnC12, was incubated without or with increasing concentrations of 
histone H2b (.008 - 1.0 mg/ml) in buffer containing 50 mM Hepes, 0.1% 
Triton X-IOO, pH 7.4 for 4 min at 25 0 C. After separation of free and 
bound ATP with Centricon 10 miniconcentrators at 4oC, free ATP 
concentration was measured by UV absorption at 259 nm with a spectro-
photometer. 
Kinetic analysis: Kinetic constants for reactions involving 
substrate inhibition were determined by non-linear least squares fit of 
the data to the equation V - (Vmax*[S])/(Km + [S] + [S]2/Ki) as 
described by Cleland (41). Kinetic constants for uninhibited reactions 
were obtained either by fitting to the non-linear form of the 
Michaelis-Menten equation by least squares analysis as described (67) 
or by conversion of the data to double-reciprocal plots and analysis by 
linear regression. When analyzed both ways, constants obtained by 
non-linear and linear regression were similar. Kinetic constants 
obtained from data in the absence of insulin are not shown as the low 
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activity in the absence of insulin precluded accurate estimates of the 
constants. 
Statistical analysis: Statistical analyses were performed by the 
Students t-test or paired Students t-test when control and diabetic 
derived receptor preparations were assayed in pairs. Analysis of 
variance (Peritz' F-test) was performed on data involving an insulin 
dose response. 
RESULTS 
Kinetics of insulin receptor kinase activity towards H2b: To 
examine the effect of substrate inhibition on insulin receptor kinase 
activity towards H2b, histone H2b was incubated with insulin receptors 
without or with prior exposure to insulin and before addition of ATP. 
The resulting histone dose response curve was biphasic (Fig la) with 
receptors isolated from both control and diabetic rats in the absence 
and presence of insulin. Inhibition of insulin-stimulated kinase 
activity occurred at much lower levels of H2b than inhibition of basal 
kinase activity. In the presence of insulin and low concentrations of 
H2b, (0.2 - 0.5 ug/m1) the tyrosine kinase activity towards this 
substrate of receptors isolated from livers of diabetic rats was either 
not significantly different or significantly increased when compared to 
controls by paired t-test. However, in the presence of insulin and 
higher concentrations of H2b, (.001 - 1 mg/ml) tyrosine kinase 
activity of diabetic-derived receptors was significantly lower than 
that of controls. Lineweaver-Burke plots of the insulin stimulated 
data were curvilinear indicative of substrate inhibition (fig Ib). 
These data suggested that one or more kinetic constants (Km,Ki or Vmax) 
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was altered with receptors isolated from diabetic rats compared to 
controls. Table 1 shows the kinetic constants obtained from curves in 
the presence of insulin. The Kmapp and Vmaxapp for H2b of ,diabetic-
derived receptors was significantly lower than that of controls. The 
Kiapp for inhibition of exogenous kinase activity was not significantly 
different between the two groups. 
Inhibition of autophosphorylation by H2b: To assess the effects 
of H2b addition prior to receptor activation on autophosphorylation, 
radioactivity incorporated into the a subunit of the insulin receptor 
was determined in the experiments described in fig lao Histone inhibi-
ted autophosphorylation of receptors isolated from diabetic and 
control rats in a dose-dependent manner (fig lc). Insulin stimulated 
autophosphorylation was significantly lower in receptors isolated from 
diabetic rats compared to controls at all concentrations of histone in 
this experiment (fig la), whereas there was no apparent difference 
between diabetic- and control- derived receptors in the concentration 
of histone eliciting half maximal inhibition (Kiapp ) of insulin 
stimulated autophosphorylation (-0.4 mg/ml). This concentration was 
-10 fold greater than the Ki for inhibition of exogenous kinase 
activity, indicating that inhibition of exogenous kinase activity is 
not a direct result of inhibition of total autophosphorylation. 
Effect of histone on free ATP: To test the possibility that 
inhibition in these reactions could be due to binding of ATP by high 
levels of H2b, free ATP concentrations were measured in a separate 
reaction after addition of increasing concentrations of histone H2b to 
25 tiM ATP or Mn2+-ATP (Fig 2). In the absence of Mn2+, an H2b concen-
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tration-dependent diminution of free ATP was observed above 0.2 mg/ml 
H2b. However, in the presence of 5 mM Mn2+, no effect of H2b on free 
ATP was observed. These results indicate that the inhibition by H2b is 
not due to a reduction in free ATP since Mn2+ (5 roM) was included in 
all kinase assays. 
ATP kinetics: The following experiment was performed to determine 
the mechanism of insulin receptor tyrosine kinase inhibition by H2b and 
to assess whether differences in the inhibition pattern of receptors 
from control and diabetic rats was due to altered ATP kinetics. 
Receptors isolated from livers of control and diabetic rats were 
incubated with insulin, followed by a concentration of histone which 
did not alter free ATP concentration under either of the conditions 
tested above (0.008 mg/ml), or a concentration of histone which 
markedly decreased free ATP concentration (0.4 mg/ml) in the absence of 
Mn2+; prior to addition of increasing concentrations of ATP (5 - 150 
uM) (Fig 3a). Maximal velocity of histone phosphorylation was 
achieved in all reactions at -25 uK ATP. The inhibition of kinase 
activity by high levels of H2b (0.4 mg/m1) was not overcome by in-
creasing ATP concentrations up to 150 uK. Differences between the 
velocities of diabetic- and control- derived insulin receptor kinase 
activities towards H2b persisted at all ATP concentrations. 
Lineweaver-Burke plots of the data are shown in fig 3b. Kinetic 
constants obtained after analyzing the data are shown in Table 2. 
In the presence of 0.4 mg/ml H2b, the Kmapp for ATP of control-derived 
receptors was significantly lower than that observed in the presence of 
.008 mg/ml H2b (9.44 + 1.69 uK) when analyzed by paired t-test (n-6 
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pairs, p < 0.05). High concentrations of H2b also decreased the Kmapp 
of the diabetic receptor for ATP by the same magnitude (- 2 fold) 
although this difference did not reach statistical significance. In 
both groups, Vmaxapp was significantly lower (-2 fold) in the presence 
of 0.4 mg/ml H2b than with 0.008 mg/ml (p < 0.05 by paired t-test, n-6 
pairs). These data rule out competetive binding or sequestration of 
ATP by H2b. A decrease in both Vmax and KID for ATP by H2b is 
indicative of a mixed type inhibition. 
The Vmaxapp for ATP of diabetic-derived receptors at 0.008 mg/ml 
and at 0.4 mg/ml H2b was significantly lower (-2 fold) than that of 
receptors derived from controls (p <0.05 by paired t-test, n-6 pairs). 
The Kmapp for ATP of receptors isolated from diabetic rats was not 
significantly different than that of controls at either H2b 
concentration tested. These data suggest that differences in the 
inhibition pattern between control and diabetic derived receptors.are 
not due to differences in available ATP levels. 
Kinetics of H2b kinase activity after activation of receptors 
with insulin and ATP: In an attempt to prevent inhibition of auto-
phosphorylation and exogenous kinase activity, receptors isolated from 
control and diabetic rats were incubated with a maximally activating 
concentration of insulin (10- 7 M) and ATP (100 uM) prior to H2b 
addition (Fig 4a). Resulting Lineweaver-Burke Plots are shown in fig 
4b. The parabolic nature of these plots could indicate that there is 
still some inhibition by H2b or alternatively, positive cooperativity 
in substrate binding (napp = 2 by Hill plot, not shown) (243). Kinetic 
constants obtained by analysis of these data by the same method used 
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for the data presented in fig 1 are shown in Table 3. The Km, Ki and 
Vmax were not significantly different between the two groups when 
analyzed this way (inhibition by H2b) , or after linear ~egression 
analysis of double reciprocal plots of velocity vs [H2b]2 (positive 
cooperativity (243) nor after fitting the data to the non-linear form 
of the Michaelis-Menten equation (regular Michaelis-Henten kinetics). 
The lack of significant differences in Km or Vmax towards H2b between 
control- and diabetic- derived receptors may be due to the relatively 
large standard error of the measurements in this assay. Therefore, WGA 
eluates derived from diabetic and control rats were also preactivated 
with 25 uM ATP and exogenous kinase activity assayed at 4°C. Under the 
latter conditions, the Km for H2b was increased compared to the former 
conditions (compare table 4 with table 3) allowing the use of higher 
receptor concentrations; and coupled with the higher specific activi-
ties obtainable at 25 uM ATP vs 100 uM, increased total counts were 
obtained. Under these conditions, no apparent inhibition of exogenous 
kinase activity was observed at high levels of H2b (fig Sa). When data 
were fit to the non-linear form of the Michaelis Menten equation no 
significant difference in the Km for H2b was found between control and 
diabetic derived receptors whereas the Vmax was significantly lower in 
the diabetic-derived preparation (Table 4). However, this decrease in 
Vmax was of much smaller magnitude (-25%), compared to the decrease in 
Vmax when H2b was added to assays prior to autophosphorylation (-70%, 
see table 1). 
Autophosphorylation in prephosphorylated assays: When histone was 
added after ATP, we did not observe inhibition of control- or diabetic· 
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derived insulin receptor autophosphorylation (figs 4c and 5b). Total 
phosphate incorporated into the 8 subunit of diabetic and control-
derived insulin receptors was not significantly different in this 
experiment. In numerous experiments (data not shown) we observed 
considerable variability in autophosphorylation of diabetic insulin 
receptors isolated from liver (-50-100% of controls). The reasons for 
this are unclear but may be due to variability in phosphorylation of 
different tyrosine residues. Since this set of experiments was 
performed on a different population of control and diabetic receptors 
than those described in fig 1 (where autophosphorylation was decreased 
in diabetics) an experiment was carried out to ensure that the 
differences in exogenous kinase activities of prephosphorylated 
receptors vs non-prephosphorylated receptor exogenous kinase activity 
(fig 4 and 5 vs fig 1) did not reflect differences in the autophos-
phorylation ability between different receptor popUlations. In this 
experiment, receptors which had been used to obtain the data in figure 
5 were incubated without or with 10- 7 M insulin, in the absence or 
presence of .0003 or 0.4 mg/ml H2b and allowed to phosphorylate as 
described in the legend to figure 1. Results from this experiment 
showed no significant difference in autophosphorylation between control 
and diabetic receptors without or with H2b even though 
autophosphorylation was inhibited (-50%) in both groups in the presence 
of 0.4 mg/ml H2b (data not shown). Furthermore, exogenous kinase 
activity of diabetic-derived receptors was -2 fold greater than that of 
controls in the presence of .0003 mg/ml H2b and -2 fold less than that 
of controls in the presence of 0.4 mg/ml H2b (p < 0.05, n~6). 
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Therefore the same trends in exogenous kinase activity as described in 
fig 1 were observed in the absence of significant differences in 
autophosphory1ation between diabetic- and control- derived receptors. 
Kinase activity towards poly glu-tyr (4:1): Since discrepancies 
have been reported in the effect of STZ-diabetes on kinase activity 
towards Poly-Glu Tyr (4:1), exogenous kinase activity towards this 
substrate was measured with receptors isolated from livers of control 
and diabetic rats after incubation without or with increasing 
concentrations of insulin. A saturating concentration of substrate was 
then added before activation of insulin receptors with ATP. This 
concentration of substrate (2 mg/m1) results in marked inhibition of 
autophosphorylation without apparent inhibition of exogenous kinase 
activity (Morrison and Pessin (186) and data not shown), Figure 6 
shows the insulin dose-dependent increase in kinase activity towards 
this substrate in receptors from controls and diabetics. No 
significant difference in kinase activity between the two groups was 
detected at any insulin concentration. 
Kinetics of kinase activity towards poly glu·tyr (4:1): Experi-
mental truncation of the insulin receptor has been shown to have no 
effect on autophosphorylation or kinase activity towards saturating 
levels of poly glu tyr (4:1), but markedly decreased exogenous kinase 
activity towards low concentrations of this substrate, indicating that 
at least one type of structural alteration may alter the affinity of 
the receptor for poly glu tyr (4:1). To assess whether the affinity 
for this substrate and/or substrate inhibition of receptor activation 
by this substrate is altered in diabetes, insulin receptors from 
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control or diabetic liver were incubated with increasing concentrations 
of poly glu-tyr after incubation with insulin and before addition of 
ATP. This treatment resulted in biphasic dose-response curves (Fig 7) 
similar to' that seen with histone H2b. However, unlike the reactions 
with H2b, there was no significant difference in the kinase activity 
between control and diabetic derived receptors at any substrate 
concentration. Kinetic constants derived from these data (Table 5) 
indicate no significant difference in the apparent KID, Vmax or the Ki 
of exogenous kinase activity for poly glu-tyr (4:1) between control and 
diabetic-derived receptors. 
Immunoprecipitation with anti-insulin receptor antibody: The 
substrate selective effects of diabetes indicated that the substrate 
binding domain of the insulin receptor may be altered by diabetes. 
Typically, the substrate binding sites of tyrosine kinases are located 
at the carboxyl terminus (296). In addition the carboxyl terminus of 
the a subunit is more susceptible to proteolytic degradation than other 
portions of the molecule (140,229). Proteolysis mayor may not affect 
exogenous kinase activity towards various substrates (244,290). We 
therefore examined the precipitability of insulin receptors from 
control and diabetic liver with a polyc1onal anti-insulin receptor 
antibody (anti-PS) raised against the derived peptide sequence (amino 
acid residues 1328 to 1343) near the carboxyl terminus of the a subunit 
of the human placental insulin receptor (108). The percentage of total 
binding precipitated by PS was similar to values obtained previously in 
our laboratory using the same antibody dilution (32). No significant 
difference in the precibitability of to~al insulin binding by this 
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antibody was observed between WGA eluates isolated from diabetic and 
control rats (67.9 ± 2.6% vs 73.5 ± 2.62%, respectively, n-3). 
Therefore, this immunochemical technique did not reveal differences in 
a portion of the molecule potentially involved in substrate binding. 
The data indicate that apparent differences in kinase activity observed 
between receptors isolated from diabetics and controls probably do not 
reflect preferential proteolytic degradation of the carboxyl terminus 
of the receptor in diabetic liver. 
Assessment of insulin receptor dimers and tetramers in WGA 
preparations. Equilibrium 125I-Insulin binding carried out at pH 7.6 
in high salt buffer revealed that control receptors treated with DTT 
eluted at a M.W. of -200 kD (Fig 8). Total binding was decreased -50% 
under these buffer conditions compared to control receptors which were 
not treated with OTT. (data not shown). No significant detectable 
binding was observed in fractions which eluted at a M.W. of -400 Kd 
after DTT treatment, indicating complete conversion of tetramers to 
dimers. Binding from untreated receptors isolated from control or 
diabetic liver eluted at a M.W. of -400 Kd. No binding was detected in 
fractions eluting at a M.W. of -200 Kd from any preparations not 
treated with DTT (fig 8). Total binding performed in pH 7.0, low salt 
binding buffer was decreased compared to binding in pH 7.6 t high salt 
binding buffer in WGA eluates from control and diabetic rats and all 
binding activity from native (not exposed to DTT) preparations 
assessed under these conditions eluted from the gel filtration column 
at a M.W. of -400 Kd (data not shown). Thus, dimers were not detected 
under conditions optimized for tetramers or dimers. From the data in 
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Fig 9 we estimate that we would have detected the presence of dimers in 
the native preparations had they comprised at least 5% of the total 
insulin receptor population. These data indicate that dimers were not 
present in insulin receptor preparations from control or diabetic liver 
in this study. This was confirmed by crosslinking 125I-insulin to the 
insulin receptor followed by nonreducing SDS-PAGE. (Fig. 9). Intact 
tetramers were identified in native control and diabetic receptor 
preparations (lanes A and E) in fractions eluting from the gel 
filtration column at a M.W. of -400 kD. No proteins migrating at a 
M.W. of -200 kD were specifically labelled in fractions eluting from 
gel filtration columns at a M.W. of -200 kD (lanes C,D,G and H) or -400 
kD, (lanes A,B,E and F) confirming the absence of dimers in the native 
control and diabetic WGA peparations. A specifically labelled band 
migrating at an apparent M.W. of -200 kD (lane L) was detected in 
fractions eluting from the gel filtration column at a M.W. of -200 kD 
indicating the presence of dimers in DTT-treated WGA eluates. This 
band was not present in fractions eluting from the gel filtration 
column at a M.W. of -400 kD (lane J). 
DISCUSSION 
Our results agree with a previous study by Okamato et al. (195) in 
which insulin stimulated tyrosine kinase activity towards histone H2b 
(.1 mg/ml) was decreased -50% in receptors isolated from livers of 
severely insulinopenic rats compared to controls. In the current 
study, kinetic analysis further reveals that the KID and Vmax for H2b of 
insulin receptor kinase activity purified from diabetic rat liver is 
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markedly decreased compared to controls when insulin bound receptors 
were exposed to H2b before, but not when exposed to the substrate after 
maximal autophosphorylation. When receptors were activated with 
insulin and ATP prior to addition of H2b, the KID for H2b was unaltered 
and the maximal velocity was only slightly decreased (-25%) with recep-
tors from diabetics when compared to controls. These data suggest that 
a structural alteration in the diabetic receptor manifested in the 
unactivated state render kinase activation more susceptible to inhibi-
tion by H2b. The Km, Vmax and Ki values obtained by kinetic analysis 
were at best apparent, not intrinsic values, as data were fitted to an 
equation which is dependent only on the varied substrate and may be 
used for all substrate inhibitions resulting in linear (i.e. total) 
inhibition (41,242); thus it does not account for all substrates and 
interaction factors in this system. The substrate inhibition appeared 
to be complete since reaction rates were driven essentially to zero 
(i.e. to levels observed in the absence of insulin) by high levels of 
H2b and data did not fit partial (hyperbolic) inhibition models 
(42,242). The linear substrate inhibition equation was used only as a 
simplified model to show quantitative differences between control- and 
diabetic- derived insulin receptor kinase activity. Since the kinase 
is activated by autophosphorylation during the course of the non-
prephosphorylated reactions and because there is potential for 
interactions between substrate binding sites, a more extensive 
experimental approach would be required for more accurate kinetic 
analysis and was beyond the scope of these studies. If one compares 
the kinetics of prephosphorylated vs non-prephosphorylated receptors 
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using this equation, it appears that when H2b is present during 
activation it decreases both the apparent Km and Vmax for H2b, 
consistent with a mixed type inhibition mechanism. While these effects 
are apparent in both control- and diabetic-derived receptors, the 
effect is much greater in the latter. Our data suggest more than one 
binding site for H2b per insulin receptor molecule. Since there are 2 
S subunits per receptor which could function independently as a 
tyrosine kinase, it is possible that binding of histone to one of the 
subunits inhibits activation of that subunit but increases the affinity 
of the second substrate site on the other 8 subunit. If the second 
substrate binds before activation by ATP, complete inhibition occurs. 
However, if the second 8 subunit is activated by ATP prior to binding 
of the second substrate, increased affinity towards the second 
substrate results in increased activity of the uninhibited 8 subunit 
towards H2b at low H2b concentrations. Thus, occupancy by histone on 
one 8 subunit may change the kinetics of the other. Therefore, H2b may 
act as both an activator and an inhibitor of exogenous tyrosine kinase 
activity. This model could also account for the apparent positive 
cooperative effects of H2b we observed with preactivated receptors. 
The Km for H2b in our assays was considerably lower (-.002 mg/ml) 
than reported by others (.1 - 1 mg/ml) for this substrate 
(142,156,186,303). Differences in apparent Km values between data are 
likely due to: the use of receptors isolated from different tissues 
(156,186); WGA purified vs affinity purified receptors (156,186); 
measurement of kinase activity in a solubilized system vs immobilized 
on insu1in-agarose (303) and measurement at 250 C vs 4°C (142). We 
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observed higher Km values for H2b when soluble receptors were assayed 
at 4°C (-.04 mg/ml) and after receptors were adsorbed to 
insulin-agarose beads (data not shown). When we attempted to do 
kinetic analysis of receptors adsorbed to insulin agarose beads, 
interactions of substrates with the agarose matrix were observed 
resulting in considerable depletion of the substrate. 
We did not consistently observe significant differences in 
autophosphorylation of insulin receptors from diabetic and control rats 
under conditions utilized in these assays. Furthermore, we did not 
detect differences in the ability of H2b to inhibit diabetic and 
control derived receptor autophosphorylation. While it is generally 
believed that autophosphorylation of the insulin receptor is a pre-
requisite for activation of exogenous kinase activity, numerous 
investigators have shown that total autophosphorylation does not always 
correlate well with exogenous kinase activity (227 f 269,290,303). White 
et a1. (290) recently showed that when progression of the 
autophosphorylation cascade to the 3rd critical site was blocked, 
phosphorylation of the first two sites actually increased. Similarly, 
Obermaier-Kusser et a1. (189) reported that decreases in exogenous 
kinase activity of insulin receptors isolated from muscle of patients 
with non-insulin dependent diabetes mellitus (NIDDM) correlated highly 
with the extent of phosphorylation of the third critical site but 
poorly with phosphorylation of the first two sites (189). In addition, 
decreased exogenous kinase activity without concomittant decreases in 
autophosphorylation have been reported with receptors isolated from 
livers of rats fed low carbohydrate die.ts (79) and in skeletal muscle 
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of patients with NIDDM (35). Thus, conclusions regarding the 
relationship of autophosphorylation to exogenous kinase activity cannot 
be predicated solely on measurement of total autophosphorylation. 
Shoelson et a1. (248) recently proposed that substrate inhibition by 
synthetic substrates prevents the phosphorylation of critical sites in 
the tyr 1150 domain of the insulin receptor. Inhibition by H2b in our 
assay may be due to preferential inhibition of these sites, or to 
selective alteration of the rates of phosphorylation of critical sites 
in diabetic preparations without affecting total receptor autophos-
phorylation. 
No significant differences between control- and diabetic- derived 
insulin receptor kinase activity towards poly glu-tyr (4:1) was 
detected at any substrate concentration or after exposure to several 
insulin concentrations. Similarly Truglia et al. (272) did not observe 
effects of STZ diabetes on kinase activity towards this substrate·with 
insulin receptors isolated from adipocytes after insulin stimulation in 
vitro or in situ. However, Gherzi et al. (85) reported an -50% 
decrease in exogenous kinase activity of receptors isolated from livers 
of STZ-diabetic rats compared to controls towards this substrate. The 
reasons for these discrepancies are still unclear. The Mn2+ and Mg2+ 
concentrations utilized in these studies differ. In our hands t kinase 
activity towards poly glu-tyr (4:1) is highly dependent on both the 
Mn2+ and Mg2+ concentrations in the assay (data not shown). Further-
more, we found that differences in Mn2+ and Mg2+ concentrations 
required for optimal activity towards this substrate vary depending on 
the average M.W. of the synthetic peptide. Thus, the absolute tertiary 
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structure obtained by poly glu-tyr (4:1) may depend on the Mn2+ and 
Mg2+ concentration and possibly other conditions of the assay. 
Examination of tyrosine kinase activity towards poly gl~-tyr (4:1) with 
several Mn2+/Mg2+ concentrations (1 mM/10 roM, 5 mM/10 roM, 10 roM/10 roM) 
or with 5 mM Mn2+ in the absence of Mg did not reveal significant 
differences between diabetic and control receptor kinase activity at 
several poly glu-tyr (4:1) concentrations (data not shown). Therefore, 
under conditions optimized for kinase activity towards poly-glu-tyr or 
under conditions identical to those used for the H2b assay, we could 
not detect differences in kinase activity between the two types of 
receptors with poly glu-tyr (4:1). 
Several possible mechanisms may explain why the altered tyrosine 
kinase activity of diabetic receptors is selective for substrates. 
Peptide substrates do not have as rigid a tertiary conformation as 
globular proteins and the activities of enzymes towards synthetic 
substrates do not always mimic those of proteins whose sequences they 
are derived from (38,287). Therefore, the poly giu tyr (4:1) substrate 
may fit an altered binding site more readily than a protein with 
relatively more conformational constraints such as histone H2b. 
Deletion of portions of the insulin receptor S subunit may 
abolish, decrease or have no effect on insulin receptor tyrosine kinase 
activty depending on the extent of deletion (140,244). Deletion 
mutagenesis of the carboxyl terminus of the insulin receptor did not 
affect in vitro kinase activity towards poly glu-tyr (4:1) but may have 
affected recognition of appropriate intracellular substrates (163,175). 
Conceivably, this type of deletion could impair kinase activity towards 
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one substrate and not another if deletion occurs at sites critical for 
the binding of only certain substrates. Proteolysis of the placental 
insulin receptor, presumably by an endogenously copurified protease 
(140) or of the liver insulin receptor by a membrane splitting 
proteinase (244) resulted in 88 kDa S subunits with decreased tyrosine 
kinase activity towards the synthetic substrate thr-12-lys or 
apparently decreased afffinity but normal maximal velocity towards poly 
glu-tyr (4:1), respectively. Neither of the two clipped B subunits 
were recognized by antibodies directed against residues 1327-1343 (the 
PS domain) of the insulin receptor. Since we did not detect differ-
ences in the precipitability of diabetic or control receptors with an 
antibody raised against this domain, the substrate selective effects of 
diabetes were probably not due to truncation of the receptor at the 
carboxyl terminus. 
The apparent effects of H2b could be due to H2b limiting the 
availiability of essential activators in the in vitro assay such as ATP 
(156). We found that high concentrations of H2b (> 0.2 mg/ml) 
decreased free ATP concentrations in the absence, but not in the 
presence of saturating Mn2+ concentrations. It is unlikely that the 
inhibitory effects we observed with increasing concentrations of H2b 
are due to depletion of ATP since: a.) saturating Mn2+ was present in 
all assays, b.) we observed significant inhibition at levels of H2b 
(.008 - .04 mg/ml) which did not deplete ATP in the absence of Mn2+, 
and c.) inhibition by H2b could not be overcome by increasing ATP. 
Our results therefore are in agreement with Shoelson et ale (248) which 
indicated that inhibition of tyrosine kinases by some substrates is not 
due to competition with ATP binding. Furthermore it is unlikely that 
the effects of diabetes were due to altered ATP binding or altered 
available ATP since the Km for ATP was not significantly different 
between diabetic- and control- derived receptors and because the 
effects of diabetes were not overcome by increasing ATP levels. 
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Okamoto et a1. (195) showed that decreases in insulin receptor 
kinase activity from liver towards H2b correlated with severity of 
diabetes. To control for severity of diabetes t different kinetic 
assays were either performed with the same receptor preparations, or 
when this was not possible~ effects with one assay (with one or two 
concentrations of substrate) were always pre-established before perfor-
ming the other assays on any given pair of diabetic and control 
receptor preparations. 
The detection of insulin receptor dimers in isolated liver plasma 
membranes by Koch et al. (147) and Massague et ale (170) indicated that 
the native receptor may exist in different association states. Insulin 
receptor a-a dimers were not detected in our preparations with the PEG 
precipitation or cross1inking methods. Therefore differences observed 
between diabetic- and control- derived receptor kinase activities in 
the present study were not due to the existence of dimers. The lack 
of dimers in our preparations could reflect our freezing tissues 
immediately in liquid nitrogen upon isolation followed by rapid 
solubilization instead of isolating membranes before purification of 
receptors; thus dimers may not exist natively in rat liver. but rather 
arise during isolation of receptors. 
Our results with H2b are compatible with previous observations 
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suggesting that STZ-diabetes causes structural alterations of the 
insulin receptor (30). The present study indicates that structural 
alterations in diabetes may enhance the susceptibility of activation of 
the insulin receptor kinase to inhibition by putative regulatory 
molecules. Such molecules could be high levels of substrates or 
inhibitors in vivo. A second model of insulin action has been proposed 
in light of evidence that some of insulin's effects may be elicited 
without evidence of increased kinase activity (77,100,250,305) and that 
antibodies which stimulate kinase activity mimic some but not all of 
insulin's effects (211). This model predicts that autophosphorylation 
of the receptor merely serves to alter the conformation of the 
receptor, resulting in non-covalent interactions of the receptor with 
some other plasma membrane protein similar to systems which activate G 
proteins (86,129). Our observations suggest that the diabetic receptor 
expresses altered binding to H2b and/or is less likely to change its 
conformation in response to insulin in the presence of H2b; non-
covalent interactions with other molecules in the plasma membrane may 
be altered similarly. 
In summary, our data is compatible with the hypothesis that the 
metabolic alterations associated with insulinopenic diabetes cause 
structural modifications of the insulin receptor and may result in 
enhanced substrate inhibition of the receptor kinase. Whether this 
type of regulation is relevant to in vivo insulin action is unknown. 
Since impairment of the insulin receptor tyrosin kinse activity has 
been observed in streptozotocin diabetic rats after activation by 
insulin in vivo, similar mechanisms may be operational in intact cells. 
The fact that the tyrosine kinase defect is expressed towards one 
substrate and not another in our system suggests that the reported 
discrepancies concerning the effects of diabetes on the exogenous 
kinase activity of the insulin receptor may reflect in part the 
selection of substrates studied. In addition, these results emphasize 
the importance of identifying and characterizing the endogenous 
substrates and modifiers which interact with the receptor in vivo. 
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Table 1. Kinetic constants for H2b. Tyrosine kinase activity of 





1.6 ± 0.36 
0.3 + 0.066* 
Ki 
(mg/ml) 
0.021 ± 0.014 
0.059 + 0.047 
Vmax 
(fmo1es Pi/ 
fmo1e receptor I 4 min) 
8.79 + 1.76 
2.97 ± 0.51* 
Kinetic contstants are apparent values obtained by nonlinear least 
squares analysis of the data (in the presence of insulin) presented in 
figure la, according to the method of Cleland (41). 
Data is presented as the mean + S.E. of constants from analysis of 
inidividual curves. 
*p < 0.05 compared to control by paired Student's T-test, n-6 pairs 
The M.W. of H2b~ 13,800 
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Table 2. Kinetic constants for ATP in the presence of different 





















fmole receptor / 4 min) 
3.91 + 0.40 
1.53 ± 0.33 
2.08 + 0.28* 
0.83 + 0.17* 
Kinetic contstants for ATP are apparent values obtained by linear least 
squares analysis of double-reciprocal plots of the data presented in 
figures 4a and 4b. 
Data are presented as the mean + S.E. of constants obtained from 
individual curves. 
*p < 0.05 compared to control by paired Student's T-test, n ~ 6 pairs. 
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Table 3. Kinetic constants for H2b. Tyrosine kinase activity of 
insulin receptors measured with H2b added after 





0.0041 + 0.00103 
0.0062 + 0.00454 
Ki 
(mg/ml) 
1.528 ± 1 .. 011 
1.879 ± 0.976 
Vaax 
(fmoles Pi/ 
fmole receptor I 4 min) 
10.24 ± 1.96 
7.75 + 1.08 
Kinetic contstants for H2b are apparent values obtained by nonlinear 
least squares analysis of the data (in the presence of insulin) 
presented in figure Sa, according to the method of Cleland (41). 
Data are presented as the mean ± S.E. of constants obtained from 
analysis of individual curves. 
The M.W. of H2b ~ 13,800 
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Table 4. Kinetic constants for H2b. Tyrosine kinase activi~ of 
insulin receptors with H2b added after autophosphorylation at 
4oC. 
Km Vmax 
(mg/ml) (fmoles Pi / 
fmole receptor I 30 min) 
Control 0.0393 + 0.0110 8.92 ± 1.47 
Diabetic 0.0446 ± 0.0127 6.76 ± 0.94* 
Kinetic contstants for H2b are apparent values obtained by least 
squares analysis of the data (in the presence of insulin) presented in 
figure 6, fit to the nonlinear form of the Michaelis-Menten equation as 
described (67). 
Values are presented as the mean ± S.E. of constants obtained by 
analysis of individual curves. 
The M.W. of H2b ~ 13,800 
*p < 0.01 compared to control by paired Students T-test t n - 5 pairs. 
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0.540 + 0.110 
0.562 ± 0.143 
Ki 
(mg/m1) 
7.83 ± 2.21 
9.38 + 2.95 
VDlax. 
(fmo1es Pi/ 
frno1e receptor I 4 min) 
131.48 + 17.14 
136.87 + 18.78 
Kinetic contstants for poly glu-tyr 4:1 are apparent values obtained by 
nonlinear least squares analysis of the data (in the presence of 
insulin) presented in figure 8, according to the method of Cleland 
(41). 
Data are presented as the mean + S. E.. of constants obtained by analysis 
of individual curves. 
M.W. of poly glu-tyr ~ 45,700 
lOB 
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Figure 1. Kinetics of insulin receptor tyrosine kinase activity 
towards histone H2b. Equal insulin binding activitites of YGA eluates 
derived from control and diabetic liver were incubated without or with 
10- 7 M insulin for 16 hr in buffer containing 50 roM Hepes, 0.1% Triton 
X-100, 5 mM MnC12, 0.55% BSA, pH 7.4 at 4oC, followed by increasing 
concentrations of H2b (0.2-1000 ug/ml) for 10 min. at 2SoC. 
Phosphorylati.on was ini tiated by the addi tion of 25 uM Y [32p ] ATP and 
reactions were stopped after 4 min. at 2SoC by the addition of 4X 
Laemmli's sample buffer. Following SDS·PAGE and treatment of gels with 
1 N NaOH for 1 hr. at 550C t H2b and a subunit bands were localized by 
autoradiography, excised and 32p counted by scintillation 
spectrophotometry. - - minus insulin, + - plus insulin. A: Exogenous 
kinase activity towards H2b. B: Double-reciprocal plot of data (+ 
insulin) presented in A. C: Insulin receptor autophosphorylation. 
Each point represents the mean or mean ± S.E. of 6-11 receptor 
preparations. 
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Figure 2. Free ATP concentration in the presence of histone H2b. 25 
uM ATP (ATP) or 25 uM ATP, 5 roM KnC12 (Mn-ATP) was incubated in 50 roM 
Hepes, 0.1% Triton X-100, pH 7.4, without or with increasing 
concentrations of histone H2b (1-1000 ug/ml) for 4 min. at 250 C. 
After separation of free ATP from H2b by centrifugation with Centricon 
10 miniconcentrators, ATP concentration was measured in the filtrate by 
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Figure 3. ATP kinetics of insulin receptors in the presence of histone 
H2b. Equal insulin binding activities of WGA from control or diabetic 
liver were incubated with 10- 7 M insulin in buffer containing. 50 roM 
Hepes, 0.1% Triton X-IOO, 5 roM MnCl2, 0.55% BSA, pH 7.4 for 16 hr. at 
4oC, followed by incubation with either 0.008 mg/ml or 0.4 mg/ml H2b 
for 10 min. at 250 C. Phosphorylation was initiated by the addition of 
y[32p ]ATP (5-150 uM) and reactions were stopped and samples processed 
as described in the legend to figure 1. A: Tyrosine kinase activity 
towards H2b. B: Double-reciprocal plots of data presented in A. Each 
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Figure 5. Kinetics of prephosphorylated receptors towards histone H2b 
at 4°C. Equal insulin binding activities of WGA eluates derived from 
control and diabetic liver were incubated without or with 10- 7 M 
insulin in buffer as described in the legend to figure 1. 
Phosphorylation was initiated by the addition of 25 uK Y [32p ]ATP and 
continued for 30 min at 40 C when H2b (0.04 - 1 mg/ml) was added. 
Reactions were stopped after an additional 20 min. at 4°C and samples 
were processed as described in the legend to figure 1. - - minus 
insulin, + ~ plus insulin. A: Exogenous kinase activity towards H2b. 
B: Insulin receptor autophosphorylation. Each point represents the 
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Figure 6. Insulin dose-response of kinase activity towards poly glu-
tyr (4:1). Equal insulin binding activities of WGA eluates derived 
from control and diabetic liver were incubated without or with 
increasing concentrations of insulin (0.1 - 100 nM) in buffer 
containing 50 roM Hepes, 0.1% Triton X-100, 2 roM MnCI2' 10 mM MgCI2, 
0.55% BSA for 16 hr at 4oC. Poly,glu-tyr (4:1) (2 mg/ml), was then 
added for 10 min and phosphorylation was initiated by the addition of 
25 uK Y [32p ]ATP and reactions were stopped after 4 min at 25°C as 
described in Materials and Methods. 32p waS quantified by 
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Figure 7. Kinetics of insulin receptor kinase activity towards poly 
g1u-tyr (4:1). Equal insulin binding activities of WGA eluates derived 
from control and diabetic liver were incubated without or with 10- 7 M 
insulin in buffer as described in the legend to figure 6. Poly glu-tyr 
(4:1) (0.05 - 10 mg/ml) was then added for 10 min and phosphorylation 
was initiated by the addition of 25 uM Y [32pJATP. Reactions were 
stopped after 4 min at 25°C and samples were processed as described in 
Materials and Methods. minus insulin, + - plus insuln. Each point 
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Figure 8. Equilibrium 125I-insu1in binding to isolated insulin 
receptor dimers and tetramers. Native and DTT-treated WGA eluates 
derived from control and diabetic liver were subjected to gel 
filtration as described in Materials and Methods. Fractions were 
incubated with 125I-Insulin (10- 11 M) without or with 10- 6 M unlabelled 
insulin in binding buffer (pH 7.6, 150 roM NaCl) as described in 
Materials and Methods. Receptor-bound insulin was precipitated with 
polyethylene glycol and samples were counted as described in Materials 
and Methods. The single and double arrows denote the elution of 
Ferritin (440 K) and Myosin (205 K) molecular weight standards, 
respectively from the Bio-ge1 filtration column. Data shown is a 
representative of 3 determinations. 
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Figure 9. Identification of dimers and tetramers after crosslinking 
and SDS-PAGE. Native and DTT-treated WGA eluates derived from control 
and diabetic liver were subjected to gel filtration as described in 
Materials and Methods. Fractions eluting at a M.W. of -200 kD (lanes 
C,D,G,H,K and L) or -400 kD (lanes A,B,E,F,I and J) were then incubated 
with 125I-Insulin, without (lanes A,C,E,G,J and L) or with (lanes 
B,D,F,H,I and K) 10- 6 M unlabelled insulin and proteins were separated 
by non-reducing SDS-PAGE after addition of NEM as described in 
Materials and Methods. Native control- and diabetic- derived WGA 
eluates are shown in lanes A-D and E-H, respectively. DTT-treated 
control YGA eluates are shown in lanes I-L. The single arrow 
indicates the migration of the~~ tetramer and the double arrows 
indicate the migration of the as dimer. The gel shown is a 
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CHAPTER IV 
STRUCTURAL DIFFERENCES BETWEEN MUSCLE AND LIVER 
DERIVED INSULIN RECEPTORS 
The contents of this chapter have been previously published in similar 
form in J. Bio1. Chem. 261:14361-14364. 
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INTRODUCTION 
The insulin receptor is a heterotetramer glycopeptide composed of 
two a and two S subunits which are linked by disulfide bonds (for 
review see Refs 53,225,273). Pulse-chase studies (223,237) and recent 
analysis of cDNA clones (69,273) suggest that the insulin receptor is 
synthesized as a Mr 180,000 precursor which is subsequently 
glycosylated and ~leaved to yield subunits of -135,000 and -95,000. 
Heterogeneity in the structure of the insulin receptor has been 
reported. In brain both the a (107) and 8 (220) subunits may have 
smaller Mr than those observed in adipocyte and liver, respectively_ 
The difference in the a subunit is apparently due to a decrease in 
sialic acid content (107). Gorden's group (177) reported that both the 
a and 8 subunits of insulin'receptors isolated from a human monocyte 
cell line have larger Mr than the corresponding subunits from IM-9 
lymphocytes. The 8 subunit of endothelial cells had a large Mr than 
that derived from a hepatoma cell line (120). Only in the first 
instance (107) was a molecular basis for the heterogeneity suggested. 
In this report we compared in rats the structure of the insulin 
receptor derived from the two main in vivo target organs of insulin, 
skeletal muscle, and liver. 
MATERIALS AND METHODS 
Materials: Monocomponent, crystalline pork insulin and monoiodin-
ated A14 l25I-insulin were kindly provided by Dr. Ronald Chance and Dr. 
B. H. Frank, respectively, Lilly Research Laboratories" Indianapolis, 
IN. Insulin-like growth factor-I was purchased from AMGen Biologicals, 
Thousand Oaks, CA. All other reagents and chemicals were obtained as 
previously reported (30). 
Animals: Male Wistar rats weighing 60-150 g were used. Food was 
withdrawn 24 h before decapitation by guillotine. 
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Receptor purification: The liver and hindlimb skeletal muscles 
were rapidly removed, immediately frozen in liquid nitrogen, and 
processed as described previously (31). In some experiments, addition-
al protease inhibitors (1 roM N-ethylmaleimide, 1 mg/rol bacitracin, 20 
ug/ml leupeptin. 10 ug/ml pepstatin, 1 mg/ml benzamidine, and 1 mg/rol 
benzoyl arginine ethyl ester) were added to the homogenization buffer. 
After adsorption to wheat germ agglutinin (WGA) and washing, receptors 
were eluated from the YGA column with buffer containing 50 mM HEPES. pH 
7.4, 0.1% Triton X-100, and 0.3 M N-acetylglucosamine (approximately 1 
ml/g original tissue weight for muscle and liver, respectively) and 
used directly or further purified by immunoprecipitation. In separate 
experiments previously prepared WGA eluate from liver was dialyzed 
against 50 mM HEPEs, pH 7.4, 0.1% Triton X-100, to remove N-acetylglu-
cosame. Triton X-IOO was added to the retentate (final concentration 
1%) and the receptors were added to frozen powdered muscle for reisola-
tion. 
Insulin binding: Insulin binding was performed on the WGA eluate 
as previously described (31) using A14 125I -insulin as the tracer 
(specific activity 200·250 uCi/ug, 50,000 cpm/200 u1 final volume). 
Nonspecific binding (in the presence of 10 ug/ml unlabelled insulin) 
was 4-6% of total binding in muscle and 0.5-2% in liver-derived 
receptor preparations. 
Crosslinkini: A14 l25I-insulin was cross-linked to solubilized 
insulin receptors with disuccinimidyl suberate as described (30). 
Insulin binding was measured prior to cross-linking, and equal insulin 
binding activities (30) from muscle- and liver-derived WGA eluates were 
used. 
Electrophoresis: Under reducing conditions (5% 2-mercapto-
ethanol), electrophoresis was performed using the discontinuous system 
of Laemmli (14) with a 6.5% resolving gel. The Mr of labelled bands 
was assigned by regression analysis of log molecular weight versus 
relative mobility of standard proteins supplied by Sigma, e.g. myosin, 
205,000; B-galactosidase, 116,000; phosphorylase b, 97,400; bovine 
albumin, 66,000; egg albumin, 45,000; and pepsin, 35,000. The assign-
ments are approximate since glycoproteins do not migrate according to 
their true Mr on SDS-PAGE (15). 
RESULTS AND DISCUSSION 
The a subunit of the insulin receptor solubilized from muscle and 
liver was identified by specific covalent coupling to A14 125I-insulin 
using disuccinimidyl suberate and examination of the reaction product 
by SDS-PAGE and autoradiography. When examined under reducing condi-
tions, a protein of Mr 131,000 from WGA eluate of muscle homogenates 
was labelled (Fig 1, lane G) while a protein of Mr 135,000 was labeled 
in WGA eluates from liver (Fig 1, lane E). These differences were 
130 
131 
observed without exception in seven separate receptor preparations. 
The labeling of these two proteins was prevented by adding excess 
unlabeled insulin to the radioligand prior to cross-linking (Fig 1, 
lanes A and B). The l25I-insulin cross-linked protein was identified 
as the insulin receptor a subunit (as opposed to the structurally 
similar IGF-I receptor a subunit (13» by incubating the WGA eluates 
with l25I-insulin and increasing concentrations of unlabeled insulin or 
IGF I prior to cross-linking. IGF-! was approximately 100 times less 
potent at inhibiting l25I -insulin crosslinking than native insulin (Fig 
2A). Since the smaller Mr of the muscle-derived insulin receptor 
subunit could be caused by protease degradation during isolation, 
insulin receptors from muscle and liver were isolated in the presence 
of additional protease inhibitors as described under "Experimental 
Procedures" but the difference between the CL subunits of the muscle ... 
and liver-derived insulin receptors persisted (Fig 1, lanes C and D). 
Furthermore, insulin receptors isolated from rat liver were dialyzed to 
remove N-acetylglucosamine and added to powdered frozen muscle prior to 
homogenization. The mixture was purified by the standard procedure and 
the WGA eluate was cross-linked with radiolabeled insulin; SDS-PAGE 
under reducing conditions followed by autoradiography revealed an 
approximately 2-fold widened band, the top of which comigrated with the 
liver-derived, and the bottom with the muscle derived, CL subunit (Fig 
1, lanes F and F'). 
Equilibrium binding of A14 125I-insulin to receptors in the WGA 
eluate was performed to determine whether the difference in the Mr of 
the a subunits resulted in functional alterations. The yield of 
insulin receptors per gram of original tissue weight (pmol of insulin 
specifically bound/g of tissue) was 7-10 times greater from liver than 
from skeletal muscle. Binding data were plotted in the form 
(B/F)/(Bo/Fo) versus insulin concentration to compare the relative 
affinities of the receptors for insulin directly (Fig. 2B). The 
affinity for insulin of receptors from liver and muscle was not 
significantly different when data from seven separate sets of receptor 
preparations were compared, although the apparent affinity of hepatic 
receptors appeared slightly lower. 
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The above studies were carried out in collaboration with studies 
by others in our laboratory. Additional studies identified differences 
in the molecular weight of the 8 subunit of the insulin receptor from 
muscle and liver (28). The e subunit was identified by 
autophosphorylation in the presence of [y.32p ]ATP with subsequent 
SDS-PAGE and autoradiography. When the muscle-or liver-derived insulin 
receptor was allowed to autophosphorylate, proteins of Mr 98,000 and 
101,000 respectively, were labeled. The labeling of these proteins was 
increased in the presence of insulin in a dose-dependent manner (31), 
was specifically immunoprecipitable with anti-insulin receptor 
antibodies, and was thus identified as the e subunit of the insulin 
receptor. After purification of the receptors on insulin-agarose and 
subsequent autophosphorylation the same Mr differences between muscle-
and liver-derived receptor B subunits were observed (Fig 1, lanes Hand 
J). These differences persisted when the insulin receptors were 
isolated in the presence of excess protease inhibitors, as described 
above for the a subunit (Fig 1, lanes I. and K, and Table I). 
Subsquent studies by others in our laboratory involving glycosi· 
dase digestion of individual receptor subunits before or after V-8 
protease digestion revealed differences in the glycosylation of muscle 
and liver-derived a subunits (28). The differences between B subunits 
could be partially obliterated by treatment of receptors with 
neuraminidase suggesting that differences between receptors derived 
from the two tissues is due in part to increased sia1ylation of the 
liver a subunit compared to muscle. Treatment of insulin receptors 
with neuraminidase, endoglycosidase H or the two in sequence, did not 
alter the differences in the migration of muscle and liver-derived a 
subunits, indicating that differences between the a subunits were not 
due to differences in sialic acid content or in altered processing of 
high mannose to low mannose oligosaccharides. 
In experiments comparing V-8 protease digested a subunits, the 
labeling of a phosphopeptide in the muscle-derived insulin receptor 
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subunit was observed which comigrated with the major phosphopeptide 
derived from liver (28). This slower migrating population in muscle 
was shown to increase after the induction of streptozotocin diabetes in 
the rat (30). Subsequent studies also showed that the 
insulin-stimulated tyrosine kinase activity of the liver-derived 
insulin receptor was decreased (-50%) compared to muscle (32). 
It is difficult to compare the Mr presented here to those reported 
in the literature for insulin receptors isolated from various tissues, 
due to minor differences in SDS·PAGE technique between laboratories and 
the variability in the Mr assigned to phosphorylase b, the commonly 
used standard which migrates near the S subunit. In the present study, 
it was assigned 97,400 (268) but this value varies between 92,000 and 
97,500 in various papers characterizing insulin receptor subunits. It 
was not until the muscle and liver-derived subunits were electrophor-
esed next to each other that the differences in electrophoretic 
mobility became discernible. Recent studies of insulin receptor gene 
structure suggest that while there appears to be only one copy of the 
insulin receptor gene, there is mRNA heterogeneity; in man, certain 
mRNA species predominate in liver versus other tissues (e.g. placenta 
and IM·9 lymphocytes). A salient difference between insulin's action 
in liver and a number of other tissues is a lack of insulin-stimulated 
glucose transport in the former. Morphological studies (119) highlight 
differences in the distribution of insulin receptors on the cell 
membrane in various tissues (e.g. liver versus adipocytes) which may 
reflect in part structural heterogeneity of the receptors. Whether or 
not the structural differences described here are reflected in differ-
ences in transmembrane signalling and/or have functional implications 
remains to be determined. 
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Figure 1. Autodradiogram of muscle- and liver-derived insulin receptor 
a and B subunits. YGA eluates were prepared by the standard procedure 
(lanes E, F, F', Gt H, and J) or in the presence of additional protease 
inhibitors (lanes A-D, I, and K) or from muscle homogenates to which 
previously purified liver-derived insulin receptors were added (lanes F 
and F t , see "Experimental Procedures"). In experiments shown in lanes 
A-G, WGA-purified receptors were incubated with Al4 l25I-insulin 
without or with (lanes A and B) 50 ng/ml unlabeled insulin at 40 C for 
16 hr. Disuccinimidyl suberate (2 roM) was added for an additional 15 
min when 4 X concentrated Laemmli's sample buffer was added. Lanes C 
and G illustrate cross-linked a subunits derived from muscle, and 
lanes D and E from liver; lanes F and F' illustrate the mixed 
population from muscle and liver. Electrophoresis was performed under 
reducing conditions on a 6.5% resolving gel. Lanes A-D and E-G are 
derived from separate experiments; the two autoradiograms were aligned 
according to the molecular weight markers. In experiments shown in 
lanes H-K, YGA eluates from muscle (lanes H and I) or liver (lanes J 
and K) were incubated with insulin-agarose (29) for 16 h at 4°C, 
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Figure 2. A: Specificity of cross-linking 125I-Insulin to muscle and 
liver receptors. Equal insulin binding activities of muscle- and 
liver- dervied wheat germ eluates were incubated with l25I-insulin and 
increasing concentrations of unlabeled insulin or IGF-l prior to cross-
linking with DSS as described in Fig. 1. Proteins were separated by 
SDS-PAGE and the amount of 125I -insulin cross-linked was quantitated by 
counting the excised labeled bands in a gamma counter. Each point is 
the mean of duplicate determinations. B: Equilibrium binding of A14 
125I -insulin to WGA eluates from muscle and liver. WGA eluates from 
muscle (50 ul) and liver (25 ul) were incubated as described (30) with 
A14 125I-insulin and increasing concentrations of unlabeled insulin. 
Receptor-bound l25I-insulin was precipitated wtih polyethylene glycol 
(30). Nonspecific binding was determined as that occurring in the 
presence of 10 ug/ml unlabeled insulin, and subtracted from total 
binding. The data represent the mean of seven separate receptor 
preparations from muscle and liver. 
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SKELETAL MUSCLE INSULIN RECEPTOR TYROSINE KINASE: 
EFFECTS OF SUBSTRATE INHIBITION AND DIABETES 
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INTRODUCTION 
The first known event after insulin binding is activation of the 
intrinsic tyrosine kinase of the insulin receptor. This activation 
appears to be a prerequisite for most if not all of insulin's actions 
and has been extensively characterized in vitro and to a lesser extent 
in vivo (26,129,225). Defects in kinase activity are observed in 
adipose tissue (78,251) skeletal muscle (6) and liver (34) of patients 
with non-insulin dependent diabetes (NIDDM) and experimental rat models 
of insulin-dependent diabetes mellitus (IDDM). These defects appear to 
be aquired as they can be corrected by normalization of insulin levels 
in insulinopenic rats (30,123) or by weight control in patients with 
NIDDM (80). 
We recently observed that diabetes induced decreases in liver 
insulin receptor tyrosi~e kinase activity were more pronounced under 
conditions where the receptor kinase was inhibited by the substrate 
H2b. whereas near normal maximal intrinsic exogenous kinase activity 
was observed under noninhibitory conditions. In addition no 
diabetes-related impairment of the hepatic insulin receptor 
tyrosine-kinase were observed when using the substrate poly glu-tyr 
(4:1). In the present study we examined the effects of various 
concentrations of histone H2b and poly glu-tyr (4:1) on exogenous 
kinase activity of the insulin receptor from skeletal muscle of control 
and diabetic rats. We also examined the effects of the severity of 
diabetes on skeletal muscle insulin receptor kinase activity in vitro. 
MATERIALS AND METHODS 
Materials: All materials and sources were as described previously 
in chapter 3 of this dissertation. 
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Animals: Male Wistar BR rats (Charles River laboratories, Wilming-
ton, MA) weighing 100-200 g were allowed access to standard rodent chow 
and water ad libitum. Diabetes was induced with a single intravenous 
dose of streptozotocin in citrate buffer, pH 4.5, to overnight fasted 
rats. In most studies, rats were given a dose of 85-120 mg/kg strepto-
zotocin and studied 2-3 weeks following induction of diabetes. In one 
experiment, differences in the severity of diabetes were studied after 
the injection of either 50 mg/kg or 85 mgfkg streptozotocin and the 
rats were killed one week later. Heparinized blood samples were 
obtained by cardiac puncture of anesthetized rats prior to excision of 
hindlimb muscles. 
Plasma metabolites: Glucose was measured by the glucose oxidase 
method using a Beckman glucose analyzer II. Insulin was measured by a 
double antibody radioimmunoassay as described previously (83). 
-hydroxybutyrate was measured by fluorometric assay as described 
previously (294). 
Insulin receptor purification: Muscles (-2 g) from anesthetized 
control or diabetic rats were frozen in liquid nitrogen and insulin 
receptors were solubilized and partially purified by WGA affinity 
chromatography as described in chapter 3 of this dissertation. 
Insulin binding: Equilibrium insulin binding was performed as 
described previously in chapters 2 and 3 of this dissertation. 
Exogenous substrate kinase assays: In vitro exogenous kinase 
assays towards histone H2b and poly gluMtyr (4:1) with equal insulin 
binding activity (-25 fmoles) of control and diabetic insulin receptors 
were carried out as described previously (chapter 3). Separation of 
proteins by SDS-PAGE was carried out as described previously (chapters 
2 and 3). Kinase assays involving multiple substrate concentrations 
were performed on one pair of diabetic- and control- derived WGA 
eluates at a time. Data obtained using receptors prepared from muscles 
of control and diabetic rats are reported as the percent of maximal 
kinase activity obtained from control receptors in each experiment to 
minimize variability due to differences in specific activities of ATP 
between experiments. 
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Preparation. isolation and characterization of insulin receptor 
dimers and tetramers was carried out as described previously in chapter 
3 of this dissertation. 
Statistical analysis: Statistical analyses were performed by the 
students t-test or the paired students t-test when control- and 
diabetic- derived receptor preparations were assayed in pairs. 
Analysis 'of variance were performed on data from experiments with 
insulin dose-responses and differing severity of diabetes. 
RESULTS 
Inhibition of exogenous kinase activity by H2b: Figure 1 shows 
the exogenous kinase activity towards H2b of insulin receptors solubil· 
ized from control and diabetic hindlimb muscle when histone was added 
prior to receptor autophosphorylation. As previously reported with 
liver (chapter 3 of this dissertation) increasing the concentration of 
H2b to .008 mg/ml and above under these conditions resulted in an 
obvious reduction in exogenous kinase activity towards this substrate. 
However. at the lowest concentration of H2b tested (.008 mg/ml) there 
was no significant difference in the kinase activity between receptors 
derived from control and diabetic muscle, while a significant decrease 
was observed in diabetic liver at this concentration compared to 
control liver (chapter 3, fig la). At higher concentrations of H2b 
(.04 - 1 mg/ml) the insulin stimulated kinase activity of receptors 
from diabetic muscles was significantly lower than that of receptors 
from control muscle when analyzed by paired t-test. Basal kinase 
activity was also inhibited by H2b and like liver, this inhibition was 
observed at higher levels of H2b than the insulin stimulated reaction. 
Significant differences between basal kinase activity of control and 
diabetic-derived insulin receptors were also found only at su~strate 
concentrations which resulted in inhibition of exogenous kinase 
activity (0.2 - 1 mg/ml). These results indicate that, similarly to 
liver, the diabetic derived muscle receptor kinase appears to be 
inhibited more than that from controls in the presence of H2b. 
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However, receptors derived from diabetic muscle are inhibited to a 
lesser extent by this substrate than receptors from diabetic liver when 
compared to their respective controls under similar conditions (com-
pare fig 1, chapter 3 to fig 1 chapter 5). 
Inhibition of autophosphorylation by H2b: The amount of phosphate 
incorporated into the S subunit of the receptor was quantified in the 
reactions described in figure 1 and are shown in figure 2. We observed 
no significant difference in basal or insulin stimulated autophosphory-
lation of insulin receptors derived from control and diabetic muscle at 
any concentration of H2b. The Kiapp (determined by the concentration 
of histone required for half maximal inhibition) for autophos-
phorylation was similar between the two groups (-0.4 mg/ml H2b). This 
value was similar to that observed with control and diabetic liver 
(chapter 3, fig 3). 
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Tyrosine kinase activity towards H2b after activation with insulin 
and ATP: Addition of increasing concentrations of H2b to reactions 
after insulin receptors were pre incubated with ATP at 4°C resulted in a 
dose-dependent increase in exogenous kinase activity towards this 
substrate with WGA eluates isolated from muscles of control and 
diabetic rats (fig 3). No significant difference in exogenous kinase 
activity was observed between control and diabetic-derived insulin 
receptors at any concentration of H2b tested. The Kmapp and Vmaxapp 
for H2b were not significantly different between receptors isolated 
from control and diabetic muscle (0.0505 + 0.0111 vs 0.0407 + 0.0056 
mg/ml and 30.4 + 10.04 vs 27.1 ± 8.8 fmoles Pi/fmole receptor/4 min, 
respectively) under these conditions when analyzed by fitting the data 
by nonlinear regression to the Michaelis-Menten equation. Under these 
conditions, no apparent inhibition of autophosphorylation occurred and 
no significant differences between control and diabetic autophosphory-
lation were detected (fig 4). 
Kinase activity towards poly glu-tyr (4:1): In previous experi-
ments with liver, no differences in the exogenous kinase activity 
towards the synthetic substrate poly glu-tyr (4:1) were found between 
control and diabetic-derived receptors (chapter 3, fig 8). We there-
fore measured exogenous kinase activity of WGA eluates derived from 
control and diabetic muscle towards poly glu-tyr (4:1) without or after 
incubation with several insulin concentrations. Insulin resulted in a 
dose-dependent activation of both control and diabetic insulin receptor 
kinase activity towards this substrate (fig 5). While the kinase 
activity of diabetic-derived receptors assayed without or with lO-lOM 
insulin was significantly decreased compared to controls when analyzed 
by t-test, when data were analyzed by analysis of variance (Peritz' 
F-test), no significant difference was found between control and 
diabetic-derived receptors in the absence or presence of any insulin 
concentration tested. 
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Kinetics of insulin receptor kinase activity towards poly glu-tyr 
(4:1): To assess whether effects of diabetes similar to those seen 
with inhibitory levels 6f histone H2b are also expressed towards 
poly-glu-tyr (4:1), increasing concentrations of poly glu-tyr (4:1) 
were incubated with rec~ptors derived from control and diabetic muscle 
after incubation without or with lO-7M insulin. Fig 6 shows the 
resulting dose-response curves of exogenous kinase activity after 
exposure to ATP. A biphasic dose-response curve was observed with both 
diabetic and control receptors, with no significant difference in the 
kinase activity at any concentration of poly glu-tyr. These data 
indicate that as observed with liver, the diabetes associated impair-
ment of insulin receptor kinase activity appears to be selective for 
substrates in skeletal muscle. 
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Severity of diabetes: Insulin receptor tyrosine kinase activity 
towards H2b from skeletal muscle of diabetic rats was highly variable, 
(-20-100% of controls in individual pairs) when an inhibitory concen-
tration of H2b (0.4 mg/m1) was added prior to receptor activation. 
Since the metabolic response of rats to streptozotocin is often 
variable, we hypothesized that the variability in exogenous kinase 
activity may be due to variability in the degree of diabetes. There-
fore, exogenous tyrosine kinase activity towards H2b (0.4 mgjml) was 
assessed in muscle derived WGA eluates from control rats or rats given 
a moderate (50 mgjkg STZ) or high (85 mgjkg STZ) dose of streptozotocin 
in an attempt to produce a moderate or severe diabetic state (fig 7). 
Rats with moderate diabetes grew at a rate of -5 gjday while those with 
severe diabetes grew an average of -2 gjday compared to a weight gain 
of -7 g/day for controls. Rats in the moderate group were considered 
to be diabetic by elevated plasma glucose levels (448 ± 19 mg/dl) which 
were similar to the severely diabetic rats (497 + 61 mgjdl, n-3 per 
group). Plasma glucose levels in both diabetic groups were not 
significantly different from each other but were significantly 
elevated compared to controls (132 ± 2.3 mgjdl, p <.01). The exogenous 
kinase activity of receptors from muscle of severely diabetic rats 
assayed at inhibiting levels of H2b was decreased by -50% or 70% for" 
basal and insulin stimulated kinase activity, respectively, (p <.05) 
compared to concurrently assayed controls. The kinase activity of the 
moderately diabetic group was not significantly different from con-
trols in the same experiment. These results suggest that defects in 
insulin receptor kinase activity in muscle are only expressed in 
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severely diabetic rats. 
Circulatins metabolites: Circulating glucose and B -hydroxy-
butyrate levels in the plasma of control and severely diabetic rats (85 
- 120 mg/kg streptozotocin i.v.) were measured to assess whether the 
concentration of either of these metabolites correlated with the 
decreases in muscle insulin receptor kinase activity. The mean plasma 
concentrations of glucose and B -hydroxybutyrate were markedly 
increased in severely diabetic rats (Table 1). Insulin levels were 
significantly decreased, in the diabetic group, often to undetectable 
levels, therefore attempts were not made to correlate insulin levels 
with kinase activity. However, since growth is related to circulating 
insulin levels, attempts were made to correlate the percent change from 
the initial body weight at the time of sacrifice with exogenous kinase 
activity. No significant correlation was found between decreases in 
exogenous kinase activity towards H2b (expressed as % of control) and 
plasma glucose, 8-hydroxybutyrate or % change in body weight (not 
shown). 
Detection of insulin receptor tetramers and dimers: Equilibrium 
125I-insulin binding carried out in pH 7.6, high salt buffer with 
fractions eluting from gel filtration columns is shown in figure 8. 
Binding from native (not treated with DTT) receptors isolated from 
control and diabetic derived muscles eluted in fractions corresponding 
to a M.W. of -400 kD, whereas binding from DTT-treated receptors eluted 
at a M.W. of -200 kD. No binding was detected in fractions eluting at 
a M.W. of N200 kD from native control or diabetic muscle preparations, 
with insulin binding activity assayed in either pH 7.6, high salt (fig 
8) or pH 7.0, low salt buffer (data not shown; the low-salt pH 7.0 
buffer is optimal for insulin binding by dimers but not for tetramers). 
These data were confirmed by specific crosslinking of 125I-insulin to 
the insulin receptor species followed by nonreducing SDS-PAGE (fig 9). 
Dimers were identified in fractions eluting at a M.W. of -200 kD from 
gel filtration columns after DTT treatment of control receptors (lanes 
A and B) and were absent in fractions eluting at a M.W. of -400. 
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Dimers were not detected after gel filtration of native control (lanes 
E and G) and diabetic receptor preparations (lanes J and L). In the 
native preparations intact tetramers were identified in fractions 
which eluted from gel filtration columns at a M.W. of -400 kD from both 
control (lane E) and diabetic (lane J) preparations. 
DISCUSSION 
Tissue-specific differences in the structure and function of the 
insulin receptor exist (28,35,107,120,220) We reported that the a and 
B subunits of the liver insulin receptor migrate slower on SDS-PAGE 
than the corresponding subunits from muscle (28). The differences were 
attributed in part to increased sialic acid content of the a subunits 
of liver. Further studies in our laboratory and others have shown 
functional differences in insulin receptor kinase activity between 
insulin receptors derived from human placenta and liver (194); and 
between liver and muscle from rats (32) and humans (35). Insulin 
receptors derived from rat skeletal muscle possessed -2 fold greater 
autophosphorylation and exogenous kinase activity than receptors 
derived from rat liver (32), and rat liver-deriyed insulin receptors 
were -3 times more active than receptors from human placenta per 
insulin binding site (194). 
Insulinopenic diabetes results in altered structure and function 
of the insulin receptor. The B subunit of the insulin receptor derived 
from diabetic skeletal muscle was found to migrate with a higher 
M.W. app than controls; and this was attributed in part to increased 
sia1ylation of the B subunit in a subpopulation of receptors (30). 
Skeletal muscle insulin receptors from diabetic animals also possessed 
decreased insulin stimulated autophosphory1ation and exogenous kinase 
activity towards the substrates histone H2b and angiotensin II (30). 
In this study, we found differences in the effects of diabetes on the 
rat skeletal muscle insulin receptor kinase compared to what we and 
others (195) observed with liver derived receptors. 
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Like the liver insulin receptor, the skeletal muscle insulin 
receptor kinase is inhibited by high levels of the substrate histone 
H2b. although the concentrations of H2b required for inhibition are 
higher in muscle than in liver. Differences in exogenous kinase 
activity towards H2b between receptors isolated from control and 
diabetic muscle were detectable, but the concentrations of H2b required 
were 10 - 20 fold higher with muscle derived receptors than with those 
from liver. When inhibition was apparently overcome by autophos-
phorylation of the receptor prior to substrate addition, no difference 
in exogenous kinase activity was observed between diabetic- and 
control- derived receptors at any histone concentration. Under these 
conditions, no differences in the Kmapp or Vmaxapp for H2b were 
detected between the two groups. In contrast, the maximal velocity 
towards H2b of diabetic-derived liver receptors was only -75% of 
controls when assayed similarly (chapter 3, fig 6). While with both 
muscle- and liver-derived receptors from diabetic rats the major 
functional defect appear to be enhanced substrate inhibition, an 
impairment of the fully phosphorylated enzyme was only detectable in 
liver derived receptors. We previously observed significant diabetes 
associated impairment of kinase activity towards H2b after in vivo 
activation of the control and diabetic hindlimb muscle insulin receptor 
tyrosine kinase (chapter 2, fig 9). Thus, while the intrinsic fully 
phosphorylated phosphotransferase activity of the solubilized skeletal 
muscle insulin receptor kinase is unaltered in diabetic rats, in vivo 
conditions preclude complete activation of the receptor kinase per 
insulin binding site. The mechanism in vivo may be similar to that 
observed in vitro i.e. inhibition of activation by endogenous receptor 
substrates and may reflect structural alterations in the diabetic 
receptor or its microenvironment that render kinase activation more 
susceptible to substrat~ inhibition in vivo. 
A previous study from our laboratory reported a significant 
decrease in exogenous k,inase activity towards H2b in muscle derived 
insulin receptors from diabetic rats vs controls after in vitro 
activation (30). In that study solubilized receptors were adsorbed to 
insulin agarose and incubated with maximally activating levels of ATP 
prior to the histone-kinase assay. Differences in results between the 
two studies are probably not due to the use of immobilized receptors 
in the former as no significant differences in kinase activity towards 
H2b were observed when control- and diabetic- derived receptors were 
activated similarly on insulin agarose in the present study (data not 
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shown). The reasons for the discrepancies are unclear, but may involve 
differences in the severity and/or duration of diabetes. In the 
present study (Fig 3) rats were killed between 2·3 weeks after induc-
tion of diabetes while in the previous one they were killed within 5·7 
days. Very severely compromised rats (i.e. with diabetic ketoaci-
dosis) usually do not survive past one week of experimental diabetes 
without insulin replacement and therefore would not be included in the 
population of rats shown in Fig 3. 
As with liver, we did not observe differences in the exogenous 
kinase activity towards the synthetic substrate poly glu-tyr (4:1). 
Bak et a1. (9) also did not observe differences in exogenous kinase 
activity towards this substrate using skeletal muscle insulin receptors 
derived from normal volunteers and patients with insulin-dependent 
diabetes mellitus with documented insulin resistance. Substrate 
selective effects of insulinopenic diabetes on insulin receptor kinase 
activity are therefore expressed in both muscle and liver. 
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As in a previous report from our laboratory (32), insulin 
receptors derived from muscle possessed -2 fold greater autophosphory· 
lation and exogenous kinase activity towards the substrate poly glu-tyr 
(4:1) and histone H2b compared to liver. Differences in exogenous 
kinase activity between tissues were due to differences in the Vmaxapp 
towards these substrates, consistent with previous results indicating a 
population of receptors in liver which are kinase inactive (32). We 
did not detect the presence of insulin receptor dimers in control or 
diabetic muscle t or liver indicating that differences in kinase 
activities between control muscle and liver or between diabetic and 
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control muscle are intrinsic to the native tetramer. 
Numerous reports exist of the effects of noninsulin-dependent 
diabetes mellitus (NIDDM) on insulin receptor tyrosine kinase activity 
in several tissues in humans (6,34,78,251). In liver (34), adipose 
tissue (78,251) and skeletal muscle (6,189) impaired exogenous kinase 
activity towards poly glu-tyr (4:1) have been observed in patients with 
NIDDM. Our results with muscle in the rat and those of Bak et ala (9) 
in man suggest that the mechanisms responsible for altered exogenous 
kinase activity may be different in IDDM (type 1) and .NIDDM (type 2) 
diabetes. Furthermore, a severe metabolic disorder is required before 
decreased exogenous kinase activity is observed in vitro in muscle of 
rats with STZ-diabetes; whereas in NIDDM, kinase defects are observed 
with moderate metabolic alterations. Okamoto et ala (195) observed 
decreases in exogenous kinase activity towards H2b of receptors derived 
from liver of rats with moderately severe STZ-diabetes. Those results 
and results from this study suggest differences in the sensitivity of 
muscle and liver insulin receptors to insulinopenic diabetes. 
Similarly, others have observed markedly reduced kinase activities of 
receptors derived from liver of rats rendered insulin resistant by high 
fat diets (22) and fasting (10) with no significant effect on the 
insulin receptor kinase derived from skeletal muscle of the same rats. 
Thus, the muscle insulin receptor may be spared when metabolic 
alterations are relatively mild. Alterations in metabolites which 
occur in IDDM include increased circulating glucose, free fatty acids, 
glucocorticoids, catecholamines and ketone bodies (155,160,203,267). 
We and others previously showed that hypercortisolemia in rats does not 
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affect exogenous kinase activity of the adipocyte (272) or skeletal 
muscle (18) insulin receptor. Others have shown that catecholamines 
decrease exogenous kinase activity and insulin binding ~ffinity (188). 
We did not find a correlation between plasma glucose, a-hydroxy-
butyrate, or percent decrease in body weight and reduction of exogenous 
kinase activity. However, plasma samples used for these studies came 
from rats with relatively severe diabetes (i.e. average weight gain for 
all diabetic rats was essentially zero). It is possible that if a 
wider range of diabetic animals was studied (as in fig 7), correlations 
may exist between these parameters and exogenous tyrosine kinase 
activity. 
In humans with IDDM, insulin resistance is related to the degree 
of control of diabetes (58,173). While insulin resistance is not the 
primary defect in IDDM (160,203) it is a prominent feature of diabetic 
ketoacidosis (155,203). Skeletal muscle, due to its mass is 
responsible for most of the insulin stimulated glucose transport and 
utilization of the organism (59,141); and for the same reason, when 
defective, is also the major site of insulin-resistant glucose 
transport and utilization (55). -Defects in muscle insulin receptor 
tyrosine kinase activity were observed only in severely "diabetic rats 
suggesting that impaired skeletal muscle insulin receptor signalling 
may contribute to the severe insulin resistance observed in diabetic 
ketoacidosis. 
Table 1. Tyrosine kinase activity towards H2b, plasma glucose and 
plasma ~-hydroxybutyrate levels fro. control and diabetic 
rats. 
H2b Kinase Activity 





Control 100 + 3.0 (25) 144 ± 4.3 (14) 240 ± 12.7 (33) 
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Diabetic 71 ± 3.1 (46)* 593 + 2.95 (23)* 2057 + 220 (44)* 
Results are presented as the mean ± S.E. 
Values in parentheses ~ number of rats per group 
*p < 0.01 compared to controls 
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Figure 1. Inhibition of exogenous tyrosine kinase activity by H2b. 
Equal insulin binding activities of WGA eluates derived from control 
and diabetic muscle were incubated without or with 10- 7 M insulin for 
16 hr in buffer containing 50 mM Hepes, 0.1% Triton X-100, 5 mM MnCI2' 
0.55% BSA, pH 7.4 at 4oC, followed by increasing concentrations of H2b 
(0.008 - 1 mg/m1) for 10 min at 250 C. Phosphorylation was initiated by 
the addition of 25 tiM y [32p ]ATP and r~actions were stopped after 4 min 
at 25°C by the addition of 4X Laemm1i's sample buffer. Following SDS-
PAGE and treatment of gels with 1 N NaOH for 1 hr at 55°C, H2b and 
subunit bands were localized by autoradiography, excised and 32p 
counted by scintillation spectrophotometry. - - minus insulin, + -
plus insulin. Data represents the mean ± S.E. of 4-7 receptor 
preparations. *p < 0.05 by paired t-test (n~4 pairs, minus insulin; n-7 
pairs, plus insulin). 
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Figure 2. Inhibition of autophosphory1ation by H2b. Quantification of 
insulin receptor autophosphorylation in reactions described in figure 
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Figure 3. H2b kinase activity of insulin receptors after 
prephosphorylation at 4°C. Equal insulin binding activities of WGA 
eluates derived from control and diabetic muscle were incubated without 
or with 10- 7 M insulin in buffer as described in the legend to figure 
1. Phosphorylation was then initiated by the addition of 25 uK Y 
[32p ]ATP. After 30 min at 4°C, histone H2b (0.04 -1.0 mgjml) was added 
and reactions were stopped after an additional 20 min at 40 C by the 
addition of 4X Laemmlits sample buffer. Proteins were then separated 
by SDS-PAGE and the gels processed as described in the legend to figure 
1. Data represents the mean + S.E. of 5-6 receptor preparations. 
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Figure 4. Autophosphorylation of control and diabetic derived muscle 
insulin receptors. Quantification of 32p incorporated into the 
subunits of the insulin receptors in reactions described in the legend 
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Figure 6. Kinetics of insulin receptor kinase activity towards poly 
glu-tyr (4:1). Equal insulin binding activities of WGA eluates derived 
from control and diabetic muscle were incubated without or with 10- 7 M 
insulin in buffer as described in the legend to figure 5. Poly glu-tyr 
(4:1) (0.05 - 10 mg/m1) was then added for 10 min. Phosphorylation was 
initiated by the addition of 25 uM y[32p ]ATP and reactions were 
stopped after 4 min at 2SoC as described in Materials and Methods. 
- - minus insulin, + = plus insulin. Each point represents the mean ± 
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Figure 7. Severity of diabetes. Tyrosine kinase activity towards H2b 
(0.4 mg/ml) was as~ayed as described in legend to figure 1 with WGA 
eluates derived from muscle of control rats and rats rendered diabetic 
with a moderate (50 mg/kg) or high (85 mg/kg) dose of streptozotocin. 
Data represent the mean + S.E. of 3 receptor preparations. 
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Figure 8. Equilibrium 12SI-Insulin binding to isolated insulin 
receptor dimers and tetramers. Native and DTT-treated WGA eluates 
derived from control and diabetic liver were subjected to gel 
filtration as described in Materials and Methods. Fractions were 
incubated with 125I-Insulin (10- 11 M) without or with 10. 6 M unlabeled 
insulin in binding buffer (pH 7.6, 150 mM NaCl) as described in 
Materials and Methods. Receptor-bound insulin was precipitated with 
polyethylene glycol and samples were counted as described in.Materials 
and Methods. The single and double arrows denote the elution of 
Ferritin (440 K) and Myosin (205 K) molecular weight standards, 
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Figure 9. Identification of dimers and tetramers by SDS-PAGE after 
crosslinking with l25r-rnsulin. Native and DTT-treated WGA eluates 
derived from control and diabetic muscle were subjected to gel 
filtration as described in Materials and Methods. Fractions eluting at 
a M.W. of ~200 kD (lanes A,B,C,D,G,H,K and L) or -400 kD (lanes E,F,I 
and J) were then incubated with 125I-Insulin, without (lanes 
A,B,E,G,J, and L) or with (lanes C,D,F,H,I, and K) 10- 6 M unlabelled 
insulin, and proteins were separated by non-reducing SDS-PAGE after 
addition of 2 roM NEM as described in Materials and Methods. Fractions 
from native control- and diabetic-derived WGA eluates are shown in 
lanes E-H and I-L, respectively. Fractions from DTT-treated control 
WGA eluates are shown in lanes A-D. The single arrow indicates th 
migration of the a282 tetramer and the double arrows indicate the 
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CHAPTER VI 
SUMMARY AND CONCLUDING REMARKS 
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Studies in the preceding chapters concerned the role of the 
insulin receptor tyrosine kinase in insulin resistance with particular 
emphasis on the insulin resistance which occurs in response to insulin-
openia. Soon after the initial discovery of the tyrosine kinase 
activity intrinsic to the insulin receptor, a number of laboratories 
demonstrated that in some insulin resistant states the insulin receptor 
possessed decreased tyrosine kinase activity. Those studies were the 
among the first to suggest a role of the insulin receptor tyrosine 
kinase in insulin action. The studies in this dissertation were 
initiated during that time, when it was still controversial whether the 
receptor kinase was essential to the signalling process. Studies 
concerning the in vivo activation of the insulin receptor in chapter II 
were among the first to show insulin dose-dependent activation of the 
insulin receptor in skeletal muscle in the intact rat. These studies 
were ongoing when cloning and mutation of the insulin receptor gene 
provided convincing evidence that activation of the insulin receptor 
kinase was necessary for signal transmission by the receptor 
(40,68,71). 
Insulinopenic diabetes is accompanied by increases in several 
hormonal insulin antagonists including glucocorticoids (267). Some of 
the studies presented in chapter II were carried out to establish 
whether glucocorticoids decrease insulin receptor tyrosine kinase 
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activity. These studies indicated that glucocorticoids antagonize 
insulin's actions at steps distal to the insulin receptor kinase. 
Similar studies in other laboratories subsequently showed that 
glucocorticoids do not impair the rat adipocyte (272) or liver (132) 
insulin receptor kinase. These three studies indicate that in the 
three major physiologic target tissues of insulin, the insulin 
resistance of glucocorticoid excess is a true post-receptor defect. 
However, it appears that under post-absorptive conditions, the 
instrinsic tyrosine kinase activity of the rat liver insulin receptor 
is reduced in the presence of glucocorticoids indicating a permissive 
role of glucocorticoids in altering the insulin receptor kinase in some 
nutritional states (132). Similarly, glucocorticoids may playa role 
with other hormones resulting in reduced kinase activity of the insulin 
receptor in diabetes. Measurements of insulin receptor tyrosine kinase 
activity from adrenalectomized diabetic rats are warranted in the 
future to address this issue. 
All of the studies prior to initiation of those in this disserta-
tion which addressed the effects of insulinopenic diabetes on insulin 
receptor kinase activity were performed with detergent solubilized, 
partially purified receptors activated by insulin in vitro 
(30,85,123,195). It remained important to establish whether activation 
of the insulin receptor kinase in vivo was impaired in the 
streptozotocin rat model before further attempts were made to 
characterize the receptor defect. Studies in chapter II utilized a 
method developed previously in our laboratory to assess the in vivo 
activation state of the receptor in an in vitro system. These studies 
showed that activation of the skeletal muscle insulin receptor kinase 
is markedly reduced in vivo by insu1inopenic diabetes. 
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Studies were undertaken to characterize defective insulin 
receptor tyrosine kinase activity from diabetic muscle and liver 
(chapters III and IV). Defects in insulin receptor kinase activity 
from diabetic liver and muscle were observed with histone H2b but not 
poly glu-tyr (4:1). Kinetic studies with histone H2b revealed that 
while the intrinsic kinase activity (e.g. after maximal autophosphory-
lation) of the insulin receptor from diabetic rat liver (chapter III) 
is slightly impaired, it appeared that a major reduction in exogenous 
kinase activity towards this substrate was due to inhibition of 
activation by H2b. Similar results, e.g. decreased exogenous kinase 
activity towards H2b due to inhibition by H2b were observed in recep-
tors derived from diabetic compared to control muscle (chapter V), 
although the kinase defect in receptors from diabetic muscle appeared 
to be solely due to inhibition by H2b. After maximal activation of the 
insulin receptor in vitro, kinase activity of the diabetic skeletal 
muscle insulin receptor was essentially the same as controls. Compari-
son of the results obtained in vitro and in vivo with diabetic muscle 
suggest that the environment in vivo must modulate diabetic skeletal 
muscle insulin receptor kinase activity. These modulators may inhibit 
exogenous kinase activity by a similar mechanism as H2b. 
Kinetics of H2b kinase activity from liver (chapter III) 
suggested that the insulin receptor tetramer contains more than one 
substrate binding site. The simplest interpretation of the data was 
that binding of substrate to one of the subunits in the tetramer 
complex alters the kinetics of the other subunit. Substrates for the 
receptor kinase may thus act as activators at low concentrations, and 
as inhibitors at high concentrations. This may be an important means 
by which activity of the insulin receptor can be regulated depending on 
availability of substrates and in addition the structure of available 
substrates in the cell. Since studies in this dissertation were 
primarily concerned with comparison of the kinetics of control and 
diabetic insulin receptors, further studies are necessary to test the 
above hypothesis concerning substrate regulation of insulin receptor 
kinase activity. 
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One of the recurring conclusions from all of the studies present-
ed in this dissertation was the necessity of defining and character-
izing the endogenous substrates for the insulin receptor. Methodologi-
cal difficulties have obfuscated considerable effort by others in our 
laboratory and elsewhere to elucidate relevant substrates until very 
recently (45,214). Histone H2b is a lysine-rich subfraction of mixed 
histones. Lysine rich peptides (po1ylysine, H2b and the carboxyl 
terminus of the human C-ki-ras 2 gene product) are required as 
cofactors for the in vitro insulin-stimulated phosphorylation of some 
receptor substrates including calmodulin (90,130,231,235). This 
suggests that basic amino acids may be important for interaction of the 
insulin receptor with other molecules. The effects observed with H2b 
in the studies presented in chapter III and V may be a model for the 
interaction of the insulin receptor with other basic proteins. It is 
noteworthy that the c-ki-ras 2 gene product is a member of the highly 
conserved family of G proteins (37,231) .. Recent studies which 
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demonstrated the hydrolysis of an inositol-glycan mediator following 
insulin stimulation of intact cells suggests that insulin activates an 
inositol-specific phospholipase C in the plasma membrane of cells. In 
well defined systems, phospholipase C activation occurs after 
interaction of specific receptors with G proteins in the plasma 
membrane (43,241). Although it is unclear at this time whether this 
function is mediated by a G protein, studies have shown evidence for 
interaction of the insulin receptor with G proteins (153,190,230). 
Furthermore, intracellular microinjection of anti-p2~ ras antibody 
inhibits insulin stimulated maturation of Xenopus oocytes (150). Of 
particular relevance to the present -studies (chapters III and V) is 
that P21 ras inhibits autophosphorylation of purified insulin receptors 
(191). Therefore, potentially, an alteration in the receptor by 
diabetes which alters its interaction with an insulin responsive G 
protein could alter insulin's effects. Conversely, antagonism of' 
insulin's actions by hormones known to activate specific G proteins 
(hormones which increase cAMP or activate protein kinase C) could arise 
by an interaction of these G proteins with insulin receptors to inhibit 
insulin's actions. 
Metabolic effects of insulin are often tissue specific. The 
classic response to insulin, i.e. glucose transport, is insulin-
independent in liver, whereas muscle and adipose tissue are largely 
dependent on insulin to stimulate glucose transport into cells. The 
evolutionary development of protein isotypes confers tissue-specificity 
to enzymes such as lactate dehydrogenase. Studies in chapter IV 
showed tissue-specific differences in the structure of muscle and 
liver-derived insulin receptors. Further studies by others in our 
laboratory showed that the muscle-derived insulin receptor possesses 
approximately 2-fold greater intrinsic autophosphoryla~ion and exogen-
ous kinase activity than liver (32). Whether the differences in 
structure and function result from preferential expression of different 
mRNA isoforms needs to be established. 
Comparison of the results in chapters III and V highlighted 
apparent tissue-specific differences in the response of the insulin 
receptor to insulinopenic diabetes. Variability in the tyrosine 
kinase activity of insulin receptors derived from diabetic muscle was 
partly explained by variability in the severity of diabetes. These 
studies and studies by others of the response of the skeletal muscle 
and liver insulin receptor to fasting and high fat feeding suggest that 
the insulin receptor from muscle is "spared" under mildly altered 
metabolic conditions while the insulin receptor from liver is not. 
In summary, insulin receptor tyrosine kinase activity is 
modulated in some but not all insulin resistant states. Regulation of 
insulin receptor tyrosine kinase activity in type 1 diabetes appears 
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to be different from that in type II diabetes. Regulation of insulin 
receptor tyrosine kinase activity in type 1 diabetes may be tissue 
specific. Furthermore the availability and structure of substrates may 
modulate regulation of insulin receptor tyrosine kinase activity in 
vivo in cells from insulinopenic organisms. 
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